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Topic 1. Biomedical ethics (bioethics) as an interdisciplinary 
approach. Definition, subject, objectives, principles and history  
of bioethics 
 
Main lecture questions:  
1.1  Biomedical ethics: subject, objectives and tasks 
1.2  Medical ethics history 
1.3  Main bioethical theories and principles 
1.4 Communication between healthcare professionals  
and patients 
 
1.1 Biomedical ethics: subject, objectives and tasks 
Bioethics is a product of civilization at the end of the twentieth 
century. Its origin is directly related to the intensive development of 
biomedical knowledge. Hardly be denied that the line of the late 
nineteenth – early twentieth century was no less rich in discoveries and 
achievements, than the end of the twentieth century. Nevertheless, 
changes in medicine were taking a completely new character it the 
second half of the twentieth century. Modern medicine has a real 
opportunity to “give” life (in vitro fertilization), to determine and 
change its qualitative parameters (genetic engineering, transsexual 
surgery), push the “time” of death (intensive care, transplantation, 
gerontology). 
Thus, the subject, the objectives and tasks of bioethics may be 
as follows. 
Subject: the morality of human behavior in biological and 
medical industry and in health care with respect to its compliance with 
good morals and values.  
Permission of medical interventions in the human body in terms 
of law, in particular, those interventions are associated with the 
development of the biological and medical sciences. Use of biological 
sciences in the service of man in order to improve living conditions. 
Goals and objectives: 
a) protection of human rights; 
b) transplantation of organs and tissues; 
c) the use of embryonic stem cells; 
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d) gene therapy, genetic engineering; 
e) euthanasia, reproductive technologies and abortion; 
f) cloning (reproductive and therapeutic); 
g) clinical trials of new drugs and medical devices in humans 
and in animal experiments; 
h) providing assistance to dying patients (hospices, providing 
palliative care); 
i) the use of transgenic organisms in food purpose; 
j) application of nanotechnologies; 
k) biosecurity and biosafety. 
In a narrow sense, the concept of Bioethics refers to the full 
range of ethical issues in the doctor–patient interaction. Ambiguous 
situations are constantly arising in the practice of medicine as a 
product of the progress of biological science and medical knowledge, 
require constant discussion in the medical community and among the 
general public. 
In a broad sense, the term Bioethics refers to the study of 
bioethics social, environmental, health and socio-legal problems 
concerning not only the person but also any living organisms included 
in the ecosystem surrounding the man. In this sense, bioethics is a 
philosophical orientation, evaluates the results of the development of 
new technologies and ideas in medicine and biology in general. 
The term “bioethics” was introduced by the German theologian 
Frets Yakhroma in the article “Bioethics: a review of the ethical 
relationship between man and animals and plants” in 1927. 
The founder of the bioethics is an American biologist and 
biochemist researcher-humanist Van Ranseler Potter (1911–2001), 
who in the early 70-ies of XX century introduced the term “bioethics” 
into scientific use and defined its main focus. For many years he 
worked, firstly, as professor of oncology and then he was a Deputy 
Director of the McArdle Laboratory at the University of Wisconsin 
(Madison, the USA). In the 50s he was one of the first who showed a 
positive therapeutic effect of the combination of inhibitors of cell 
growth and chemotherapy in the treatment of cancer. 
V. R. Potter becomes a worthy disciple and successor of the 
ideas of O. Leopold US Environmental School (1887–1948) – the 
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famous American environmentalist, writer and public figure. At the 
time, Leopold created a special ethics – ethics of land and distributed 
its effects not only on individuals, but on all species and ecological 
communities. 
The history of bioethics is marked by a number of “high-profile” 
events related to the introduction of new medical technologies, the 
negative consequences of which culminated in the late 60-ies of XX 
century in the shares of public protest in Western Europe and America 
against the medicine and science. There was a question about the 
reliability of the protection of mankind from the “mistakes” of medical 
and biological science, from the application of science to the detriment 
of the people. 
This was preceded by several violations of ethical and moral 
principles. In the postwar period, Nuremberg process that took place 
revealed the horror of the Nazi concentration camps in 1945–1946, 
scene of the most brutal crimes that were carried out on prisoners of 
war and civilians on the orders of the Nazi regime with the complicity 
of doctors. 
“Pharmaceutical tragedy” took place in the years 1958–1961 in 
Germany: the mothers who took the drug thalidomide as a hypnotic 
during pregnancy, born about 20 thousand children with mutilations. 
The World Medical Association has sounded the alarm, and the 
declaration was adopted at Helsinki in 1964 (additions were made in 
1973, 1983, 1989, 1996, 2000). This declaration was the first 
international ethical standard for carrying out human research studies. 
The Helsinki Declaration “on the implementation of the 
recommendations of doctors in biomedical research involving humans 
as guinea pigs” emphasized the need for maximizing the requirements 
for testing on human. 
 
1.2 Medical ethics history 
Medical ethics history is divided into five stages. The short 
characteristic of each one is presented below. 
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Stage I of the Medical Ethics (8–3 thousand years BC –  
V–IV century BC (Hippocratic Oath)) 
During the Neolithic (New Stone Age, approx. 8–3 thousand 
BC) the system of scientific knowledge was created, which later would 
be called medicine. At the same time, the first stage of development 
of the science of the regulation of human behavior owns the art of 
healing, that is medical ethics. 
During the first stage of development of medical ethics there 
emerged: 
The first laws: 
1) “Helping the sick is the good, the refusal (without any good 
reasons) is evil”. 
2) “Do No Harm”. 
3) “Thou shalt not kill” (“Don’t kill”). 
The fundamental principles of medical ethics: 
 justice; 
 beneficence; 
 do no harm. 
A special contribution to the development of medical ethics at 
the first stage was made by: 
1) Socrates (469–399 BC); 
2) Aristotle (384–322 BC); 
3) Hippocrates of Cos Great (460–377 BC). 
“The first stage of the formation of the moral code of people who 
chose healing as a form of professional activity started with “emerging 
medicine” and ended with the appearance of the works of the Greek 
philosophers.” M. J. Yarovinsky (2001). 
One of the oldest medical and ethical document is the 
“Hippocratic Oath”. This oath was given by the famous school 
graduates Asclepiadae whose ancestor was considered the god of 
medicine, Asclepius. The most famous of its graduate was famous 
Hippocrates of Cos Great. 
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Hippocrates of Cos Great 
(460–377 BC) 
The oath is a document sanctifying 
life medical schools of Hippocrates 
medicine. At that time there were already 
medical schools gluttony (corporations) 
doctors. Moving into the medical 
corporation doctors should behave 
accordingly: to refrain from any 
reprehensible actions and not to drop their 
dignity. The appearance of the Hippocratic 
oath was caused by the need to dissociate 
themselves from the single doctors, various charlatans and to ensure 
public confidence in doctors to a particular school. 
The basic principle in the “Hippocratic model” of biomedical 
ethics is the rule “do no harm”. 
Thus, the first stage in the formation of the moral code of people 
who chose healing kind of professional activity, starting with the 
“emerging medicine”, concluded the advent of the works of Greek 
philosophers, especially the works of “Corps of Hippocrates”. 
By M. J. Yarovinsky “Medical Ethics” (2001). 
Stage II of Medical Ethics development is the emergence of 
monotheistic religions 
Beginning of the second stage of medical ethics is associated 
with the approval of the monotheistic religions. 
Buddhism 
The ethical principle of Buddhism is desire to do good. 
“Brothers, you have no father, no mother and no one to take care 
of you. If you do not take care of each other, then who else will? 
Brothers who honor me, but almost painful” – Buddha’s appeal to the 
monks. Legend has it that an order was given after Buddha, bypassing 
the monks’ cells, found one of them severely suffering from dysentery, 
weakened by illness, lying in his own feces. He picked him up, washed 
from head to foot, put him to bed quietly and comfortably, and then 
announced that the compassion and care to the patient are the most 
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important rules of behavior of members of the community. Since then, 
the monks began to study medicine, to treat each other and the laity. 
Christianity 
There is a tradition that Jesus was a young man who studied 
medical manuscripts for healing physical and mental ailments. 
Heal the sick – Christ teaches his disciples (Lk 10, 9.). 
According to the Holy Tradition, one of the disciples of Christ, 
An. Luke was a doctor. Healing is a profession Martyrs: Cosmas and 
Damian, Rome, the Great Martyr; Panteleimon the Healer. In the 
history of the Church there are many examples of priests and even 
bishops who were engaged in doctoring not only spiritual, but also 
bodily ailments. 
So, for example, in the Catholic fresco of the 15th century (Mark 
Cathedral, Florence, Italy) “transplantology” operation is shown – 
Saints Cosmas and Damian sew the legs of a recently deceased person 
to the body of the deacon Justinian. 
With the establishment of Christianity as the state, the dominant 
religion in Europe, Christian church took over the care and care for the 
sick and infirm. This duty lay on deacons. 
The first known science experience of artificial insemination 
was carried out in 1780 in a Catholic monastery by abbot  
L. Spallanzani. 
An Austrian monk G. Mendel became the founder of genetics. 
With the approval of the knightly orders, some of them dedicated 
themselves to caring for the sick. For example, members of the Order 
of St. Lazarus of Jerusalem cared for lepers. From the name of the 
Order of St. Lazarus there appeared the word hospital. 
In the old Russian state after the adoption of Christianity in 
monasteries there were set up wards. 
Islam 
The works of the Arab Muslim medical scientists of Central 
Asian Renaissance era have left a noticeable trace in the history of 
medical ethics. 
“Practical medical ethics” by Al Ruhavi, “Order of Medicine” 
by Ibn Abu Useybi, “Canon of Medicine” and “Firuznoma”  
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by Ibn Sina (Avicenna). Many excerpts from them have become 
aphorisms, translated into Latin and European languages. 
Carriers of medical knowledge – the priests and their assistants, 
helping the sick person, acting in accordance with religious 
regulations. It was until the medical profession became self-reliant and 
more common, thanks to the creation of the medical faculties of 
universities. 
Stage III of Medical Ethics development. Creation of medical 
faculties at universities and corporations in the union of doctors 
Medical School of Salerno was founded in the 10th century, 
which flourished in the 12th century and translated medical books from 
Arabic into Latin. It was a secular school, not a church. Its main merit 
was the creation of a new medical literature. The course comprised 3 
years of philosophy, 5 years of medicine, 1 year of practice exam, after 
receiving the license. It was the first faculty of the East. Later it began 
to open universities in Europe. 
Creation of medical faculties at universities and medical 
association in the corporation can be considered the end of the second 
and beginning of the third stage of medical ethics development. 
The first university in Russia, Moscow University, was opened 
in 1755. Faculty of Medicine started in 1758. 
The works of Dean of the Faculty of Medicine of Moscow State 
University M. J. Mudrov played a major role in the development of 
medical ethics in Russia. 
Graduates of medical schools were given the so-called promise 
of faculty, the text of which was usually an option vow. 
In the early 19th century English physician T. Percival of 
Manchester in the book “Medical Ethics” laid out “a set of established 
rules and instructions in relation to the behavior of physicians and 
surgeons in hospitals and private practice in relation to pharmacists, in 
the event that the law requires knowledge” (1803). 
In the preface, Percival indicates that the job would be called 
“medical jurisprudence”, but realized that it was wrong, because the 
laws had not yet been written for all occasions, encountered in medical 
practice. Yes, and how to write laws for the cases when the Chief 
Justice is conscience or opinion of colleagues. 
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Works of T. Percival and M. J. Mudrov summarize the third 
stage of development of medical ethics. 
Stage IV of Medical Ethics development. Deontological stage 
Deontology (from Greek deontos is Granted and logos is 
teaching) is the ethics section, which deals with debt problems and 
moral requirements. The term “deontology” was introduced by the 
English philosopher Jeremy Bentham, who used it to refer to the 
doctrine of morality in general. 
From the standpoint of medical ethics deontological theory of 
German philosopher Immanuel Kant (the second half of the 18th 
century), which he called the “categorical imperative” has the 
greatest interest. “Act so that the maxim of your will at any time can 
become a principle of universal legislation”. 
In this self-constraint a person finds true freedom, and finds true 
human dignity (as the realization in his person the dignity of all 
humanity). Kant voiced in his categorical imperative “golden rule”, 
generally accepted in the name of ethics of the biblical commandment: 
“Do unto others as you would have them do unto you”. 
Obviously, the most important principle of modern biomedical 
ethics – respect for the moral autonomy of the patient – it goes back to 
the Kant’s conception of moral freedom, responsibility and dignity. 
Stage V of Medical Ethics development (from 70th years of XX 
century) is Bioethics. 
Bioethics is the systematic study of human behavior (not just 
medical) in the life sciences and health care to the extent that this 
behavior is considered in the light of moral values and principles of 
the “Encyclopedia of Bioethics”. 
Van Rensselaer Potter examines bioethics as a “new 
discipline” which is the bridge thrown to the exact sciences and the 
humanities, or to be more precise, a bridge between biology and ethics, 
hence the “bioethics”. 
1969 – the formation of a research center in the field of bioethics 
– the Institute of Society, Ethics and Life Sciences (Hastings Center, 
New York).  
1971 – the formation of the Institute for Ethics named by 
Kennedy at Georgetown University (Washington).  
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1972 – the publication of the Bill of Rights of Patients American 
Association of hospitals. 
1974–1978 – organization of the National Commission for the 
Protection of man as the subject of biomedical and behavioral 
research.  
1978 – exit the “Encyclopedia of Bioethics” (4 volumes).  
1980 – the creation of the Presidential Commission for the Study 
of Ethical Problems in Medicine and the behavioral sciences. 
 
1.3 Main bioethical theories and principles 
The principle of “do no harm” (Hippocratic model)  
This principle was proclaimed by Hippocrates and recorded in 
his “Oath”. Obligation “to refrain from causing any harm” has become 
since the time of Hippocrates not only the main moral principle of 
medical practice, but also the moral basis of the model of interaction 
of health care workers to patients, their families, their peers and 
teachers. The “Hippocratic Oath” includes all areas of the doctor, in 
which he must follow the principle of “do no harm”: the physical 
(properly treated, choose the method of treatment, which will bring the 
least harmful side effects, do not accelerate death and abortion), socio-
psychological and legal (non-disclosure of medical confidentiality), 
moral (respect and gratitude to my teachers, colleagues). 
At the present time there are the following forms of harm that 
may be caused by the patient:  
1. The damage caused by failure to act, failure to assist someone 
who needs it. This type of injury is among the most serious 
misdemeanors health worker and entails not only a moral judgment, 
but also administrative sanctions, and in some cases, criminal 
penalties.  
2. Damage caused by negligence or malicious intent, such as an 
ax to grind. Depending on the consequences for the patient this kind 
of damage can also lead to all kinds of punishment.  
3. Damage caused by improper, reckless or unskilled Business 
Plan. This is the damage that is the result of professional medical 
personnel errors. Depending on the degree of harm caused it entails a 
different kind of punishment.  
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4. Damage caused by objectively necessary actions in this 
situation. The only form of harm that is caused almost always, but in 
varying degrees. This damage, which for causing a health worker 
carries no penalties.  
The first three kinds indicate the health worker professional 
incompetence and varying degrees of his morality deformation. 
The principle of “do good” (model Paracelsus) 
The principle of “do good” declares the moral norm perform 
actions for the benefit of the patient. This principle was first 
formulated by Paracelsus. The basis of this ethical principle of 
medicine made the ideas of Christianity that love of neighbors should 
be manifested in good works for them. 
“Model of Paracelsus” is a form of interaction between health 
care worker with the patient and his family, in which the moral 
relationship between them is one of the main elements of the therapy. 
In the model of Paracelsus leading importance is given to the 
individual personality characteristics of the patient and the 
establishment of trust between the doctor (and other health care 
professionals) and the patient. 
The principle of “respect for duty” (deontological model)  
Entered the medical ethics together with the doctrine of 
professional duty medical care workers. According to this principle, 
the provider must comply strictly with the prescribed medical ethics 
rules and regulations and in accordance with them their professional 
duties. Requirements of professional duty are strictly for performance.  
In accordance with this principle, for the health care worker  
it becomes a professional duty to follow the principles of “do no 
harm”, “do good” and other ethical principles and standards. Violation 
of the requirements of professional duty entails certain penalties 
(moral, administrative, legal). 
The principle of respect for human rights and dignity 
(bioethics)  
Bioethics is leading, as it allows to the greatest degree to realize 
the rights of the patients in relation to their life and health.  
14 
Respect for the rights and dignity of the patient is shown in 
following four ethical rules: justice, veracity, confidentiality and 
informed consent. 
The main point is that the subject of biomedical ethics primarily 
quickly accumulates new achievements, and their in-depth study to 
determine the degree of danger in the present and future in their 
application to mankind and society as a whole. (President of the 
Academy of Medical Sciences, Acad. RAMS VI Pokrovsky 1997). 
American bioethicist Robert Veatch distinguishes four models 
of relationship between a health care worker (physician) and a patient, 
existing in modern medicine: 
a) collegial; 
b) contract;  
c) engineering;  
d) pastoral (paternalistic). 
There are following principles of biomedical ethics: 
a) respect for autonomy;  
b) nonmaleficence; 
c) beneficence; 
d) justice. 
Rules of bioethics: veracity, privacy, confidentiality, fidelity, 
freedom of will and choice, informed consent. 
Autonomy is understood as a form of personal freedom, in 
which the individual performs actions in accordance with the freely 
chosen by the decision. 
Term “autonomy” includes seven main aspects: 
1) respect for the individual patient; 
2) provision of psychological support in difficult situations;  
3) giving him the necessary information (about the state of 
health and medical measures proposed); 
4) choice of the alternate embodiment;  
5) patient autonomy in decision-making;  
6) ability to monitor the progress of the research and treatment 
(by the patient);  
7) the involvement of the patient in the process of medical 
attention (“therapeutic partnership”). 
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Paternalism is traditionally prevailed in medical practice, giving 
way to the principle of cooperation. Moral value of autonomy has been 
so high that the doctor’s deed contrary to the will and desire of the 
patient was considered to be unacceptable. The American Hospital 
Association had been actively discussing patients’ rights and approved 
a bill on the rights of patients in late 1972.  
The patient’s right to autonomy was first formalized. Paramount right 
to the information necessary for informed consent was patients’ rights, 
adopted by the American Hospital Association. 
Informed consent is a voluntary patient’s acceptance of 
treatment or therapeutic procedures after providing adequate medical 
information. 
Informed consent can be divided into two stages: 
1. Provision of information.  
2. Obtaining consent. 
Stage 1. Provision of information includes the notion of 
voluntariness and competence. The doctor must inform the patient 
about: 
 nature and purpose of the proposed treatment;  
 an associated significant risk; i. e. physician should affect the 
four aspects of risk: its nature, severity, probability of its 
materialization and surprise of its materialization; 
 possible alternative to this kind of treatment (doctor gives 
advice about the most appropriate form from a medical point  
of view, but the final decision is made by the patient). 
Stage 2. Obtaining consent. Informed consent implies the non-
use by physicians of coercion, deception, threats in decision-making 
by the patient. 
Two moral theories: deontological and utilitarian dominate in 
the field of medical ethics. 
Utilitarian theory of morality is based on the belief that the 
criterion of human actions is useful (J. Bentham). 
Medical ethics is a set of regulatory principles and norms of 
behavior of health workers (doctors) due to their specific activities, 
position and the role that has been ascribed to them in the society. 
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Medical deontology is the doctrine of the principles of proper 
medical activities. 
Medical deontology is more inclusive concept than medical 
ethics, since it includes not only moral and ethical aspects of medical 
care, but also actions of the organization, improving knowledge, skills. 
Medical deontology includes the following sections of specific 
knowledge: 
 relationship between the doctor (medical officer) with the 
society and the state; 
 principles of behavior, relationships and actions of the doctor 
(medical officer) in relation to the patient and the people around him, 
especially to close relatives;  
 the relationship between a doctor and medical staff. 
Confidentiality rules in terms of specialization and 
computerization of medicine:  
1. Rules of the case histories.  
2. Privacy and communication with relatives of the patient. 
3. Anonymity of medical information in scientific 
demonstrations and publications.  
4. Responsibility for violation of the principle of medical 
confidentiality.  
5. Possible confidentiality restrictions. 
Rules of veracity: 
1. Right, duty, the possibility and expediency always be truthful 
in the doctor–patient relationship.  
2. Veracity and incurable patients. 
3. “Holy lie” (adapted true).  
4. Placebo.  
5. Patient’s right to receive truthful information. 
 
1.4 Communication between healthcare professionals  
and patients 
There are the following types of communication:  
1. “Contact masks” is a formal communication, when there is no 
desire to understand and take into account the personal characteristics 
of the interlocutor, familiar masks are used (courtesy, modesty, 
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compassion, etc.) – a set of facial expressions, gestures, standard 
phrases that hide true emotions, attitude to the interlocutor. 
As part of the diagnostic and therapeutic interaction this kind of 
communication is evident in the cases of low medical or patient’s 
interest in the results of interaction.  
2. Primitive communication is evaluating another person as 
desired or interfering object if needed – that actively come into contact 
if interfere – “push”. 
Such kind of communication can occur within the manipulative 
communication healthcare professionals and patients in cases where 
the aim of the treatment becomes to receive any dividend (sick leave 
certificates, formal expert opinion, etc.). Formation of a primitive form 
of communication can take place at the request of a medical worker in 
cases where the patient is a man, which may depend on his well-being. 
Interest to the contact member in such cases disappears, followed by 
obtaining the desired result. 
3. Business communication is communication that takes into 
account peculiarities of personality, character, age, mood of 
interlocutor with focus on the interests of the case and not on the 
possible personality differences. 
4. Spiritual interpersonal communication is rare in the system 
(medical officer) doctor – patient. It implies the opportunity to raise 
any topic in the conversation, share any intimate challenge of each 
participant of communication.  
Diagnostic and therapeutic interaction does not imply such 
intimate contact, at least, does not provide for reasons of professional 
orientation confession health worker. 
5. Manipulative communication aimed at capitalizing on the 
interlocutor with the use of special techniques.  
The objective of such manipulation can be:  
a) reduction of the patient’s expectations of treatment success in 
connection with the avoidance of medical professional liability in the 
event of a sudden deterioration in the patient’s health; 
b) demonstration of the need for additional actions on the part of 
qualified health care professional in order to obtain compensation. 
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Types of communicative tolerance: intellectual, value–
orientation, aesthetic, ethics, emotional, sensory, algorithmic, 
characterological, functional. 
Intellectual tolerance transmits paradigm (model, type, style) of 
mental activity of a particular person, that is, the principles of his 
understanding of reality, familiar to him stereotypes of understanding 
issues, ideas, decision-making. 
Value-orientation includes basic philosophical ideals of a 
particular person, his life coming and/or long-term goals, interests, 
assessing the situation. 
Aesthetic covers an area of preferences, tastes and feelings. 
Ethics expresses the moral norms, which are followed by people. 
Emotional reflects the emotional state of the most characteristic 
for the person (joy or sadness, excitement or serenity, the rise or 
depression, anxiety or carelessness, peacefulness or aggressiveness, 
optimism or pessimism). 
Sensory characteristics include sensory perception of the world 
at the level of visual, auditory, olfactory, gustatory, cutaneous and 
motor sensations. 
Algorithmic – this substructure personality combines personal 
qualities that ensure uniformity of reproducibility. These are habits, 
skills, style of activity, different rituals, including household, family, 
religion. 
Characterological includes stable type of forming personality 
traits, congenital or acquired under the influence of the environment. 
Functional includes requirements and emerging on the basis of 
their preferences and desires. 
Models of healing can be divided into the following types. 
1. Model of “technical” type.  
One consequence of the biological revolution is the emergence 
of a physician-scientist. Scientific tradition prescribes scientist “to be 
impartial”. He must rely on the facts, avoiding value judgments. Only 
after the creation of the atomic bomb and the Nazi medical research, 
when a test is not recognized nor any rights (experiments conducted 
on prisoners of concentration camps), mankind has realized the danger 
of such a position. A scientist cannot be higher than the human values. 
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The doctor in the decision making process cannot avoid moral 
judgments and other valuable character. 
2. Sacred type model.  
The basic moral principle that expresses the tradition of sacred 
type says “providing patient care, do not cause him any harm”. Benefit 
and not to cause harm. No doctor can perform a moral duty to benefit 
and thus completely avoid injury. This principle exists in a broader 
context and is only one element of the whole set of moral duties. 
3. Collegial type model. 
The purpose of medical practice is the elimination of the disease 
and protects the health of the patient. In the model of collegial type 
trust plays a crucial role. However, ethnic, class, economic and value 
differences between people make the principle of common interests 
that are necessary for the collegial model unwieldy. 
4. Contract type model. 
Model of social relations that most closely matches the real 
conditions, as well as the principles of bioethics, historical model is a 
model based on the contract or agreement. The agreement assumes the 
principles of freedom, personal dignity, honesty, fulfillment of the 
promises and justice. This model avoids the rejection of morality on 
the part of the doctor. 
 
Questions for Self-checking 
1. What is Bioethics? 
2. Who coined the term “bioethics”? 
3. Describe main stages in history of the biomedical ethics 
development.  
4. Describe main aspects of “Hippocratic Oath”. 
5. What is the basic moral principle of bioethics?  
6. What is Deontology? 
7. What are the main principles and rules of biomedical ethics? 
8. List and describe types of communication between healthcare 
professionals and patients. 
9. What work belongs to V. R. Potter? 
10. What scientist coined the term “ethics”? 
11. Describe an informed consent. 
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Topic 2. Bioethical problems of life, dying, death  
and resuscitation. Medical, ethical and legal problems of genetic 
reproductive technologies 
 
Main lecture questions:  
2.1 Family planning and abortion 
2.2 Euthanasia: ethical and legal issues 
2.3 Transplantology 
2.4 Genetic reproductive technologies: ethicality and legality 
 
2.1 Family planning and abortion 
Family planning is an activity that helps individuals and couples 
achieve certain reproductive outcomes: to prevent unwanted 
pregnancy, birth of children desired, adjust the intervals between 
pregnancies, to control the timing of birth, depending on the age of the 
parents, and other factors to determine the number of children in 
family. This includes information on how to achieve these goals, 
providing an informed choice, the opportunity to use the full range of 
safe and effective methods of contraception. 
Family planning can include a range of activities, from the 
planning childbirth, infertility treatment and finishing with sex 
education, counseling on family life, including genetic counseling. 
However, the need to clarify the fact that none of the existing methods 
for today prevent an unwanted pregnancy cannot be considered ideal 
for all situations in life and cannot be acceptable to all cultures, 
religions and social conditions. 
Abortion, contraception and sterilization are a modern form of 
medical intervention in human reproduction. 
For the first time population growth was seriously concerned 
about the priest Thomas Malthus. In 1798, Malthus wrote his major 
work “Essay on the principles of population” (a treatise on the 
principles of population). According to the doctrine of Malthus, 
humanity is threatened by catastrophe of “absolute surplus people” 
because sooner or later there will not be enough food for people. 
Malthus calculated that the human population is growing 
exponentially, and the amount of food – in arithmetic. The way out of 
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the crisis of hunger Malthus pointed to the methods of birth control in 
the form of late marriages and self-control. 
The beginning of the XX century was marked by the rise of birth 
control policies primarily in the United States. In the second decade of 
the XX century under the wing of the Socialist Party of America 
gathered almost all the extremist forces: the radical Republicans, the 
reformists – Unitarians, “The Knights of Labor”, anarchists, populists, 
suffragettes, communists and others. A member of the party was 
Margaret Sanger – the future leader of the world’s fertility and sexual 
revolution supervisors. In 1916, she established the American Birth 
Control League, later named International Planned Parenthood 
Federation. Her multibillion business, of course, is associated with 
eugenics, and later with fascism. She opened her clinics in the poor 
neighborhoods inhabited by Slavs and South Americans, explaining 
that these people “multiply rapidly”. With the coming to power of the 
Nazi regime in Germany, its leaders began to pursue a policy of 
destruction of the Slavic races in the occupied territories, using the 
same methods and tools for reducing fertility. 
The International Planned Parenthood Federation has offices in 
almost all countries of the world and uses the ideas developed by 
Margaret Sanger and the method of genocide to reduce the birth rate 
in countries that are developing, especially in the rich mineral and 
energy resources. In some of them there is a tendency for the 
legalization of abortion. 
Now the International Planned Parenthood Federation, as well 
as 45 years ago, aims to implement birth control method worldwide 
by maens of legalization of abortion, contraception and sterilization 
distribution of the population. International Planned Parenthood 
Federation roughly despised even by international law. By convention, 
signed by most European countries, “the person, organization or 
government that uses the measures to reduce the birth rate can be 
charged with genocide”. However, the support, the governments of 
countries such as the UK, Holland, the USA, enables organizations to 
“family planning” with impunity. 
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Liberal and conservative views on issues of contraception  
and abortion 
Considering the ethical issues of abortion one cannot think of 
social movements against the West: the movements of pro-choice and 
pro-life. Liberal movement Pro-choice, from the word “choice” refers 
to the right to choose abortion. 
The main slogans of the movement are: 
1. A woman has the right to dispose of her body, so she has the 
right to choose to give birth or not to give birth. 
2. An embryo is not a human, not a child. 
3. Every child should be desired. 
4. Abortion and contraception are safe. 
Conservative movement Pro-life appeared in the West in 
contrast to the Pro-choice movement. It protects the right to life from 
the moment of conception. 
1. Embryo is not a part of the woman’s body. This is the body of 
another person because a woman’s body can dispose of at will, and 
others tell “Yes, life of another person shall dispose of it”. After all, 
the main direct right is the right to life. 
2. The embryo is a human being at any stage of pregnancy. This 
argument is an evidence of both religious (person before birth has a 
soul, because a spirit is able to communicate with God), and the natural 
sciences. From the point of view of modern biology (genetics and 
embryology) a person’s life as of a biological individual, begins with 
the fusion of male and female gametes and the formation of a single 
nucleus, which contains the unique genetic material. 
3. Other ethical issues of abortion, which always emphasize its 
opponents, include: 
 the feeling of pain and fear in the embryo during an abortion; 
 underestimation of the risk of post-abortion complications in 
the woman;  
 psycho-emotional problems, “post-abortion syndrome”; 
 complications in children born to mothers who have had 
abortions; 
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 a violation of the ethical rules by the doctors of the 
information consents as adequately inform women about the risks and 
fetal maturity (even for pregnancies up to 12 weeks). 
According to the concept of voluntary consent of the 
information, the physician must inform the patient of the 
consequences of any medical intervention. Medical abortion is the 
only surgery that is performed without a medical examination. And 
this is only the intervention, the outcome of which is not to improve 
the health of the patient, and vice versa! Human being – a child – dies, 
and reffer to women, which held abortion, causes significant health 
damage. That is, “harmless” abortion does not happen. 
The doctor scrapes the uterus, the cervix is widened blindly, 
without seeing the surgical field and therefore there is a danger of 
perforation of the uterine wall by one of the tools. 
The remains of the uterus fragments of the ovum may cause the 
development of placental polyp or accumulation of blood in the cavity 
of the uterus, which is an indication for re curettage of the uterine 
cavity. 
The remains of the ovum, placental tissue, blood in the uterus 
are a breeding ground for microorganisms. Therefore, there is a risk of 
inflammation of the uterus, pelvic peritoneum, and even sepsis. These 
complications may occur if the vagina before abortion was 
inflammation during an abortion infection got into the sterile uterine 
cavity and then into the abdominal cavity. 
Abortion can cause dysfunction of the ovaries. It’s no secret that 
even as a result of abortion may be the only infertility. Injury of muscle 
fibers during an abortion may lead to the next pregnancy failure and, 
as a result, miscarriage and cervical dystonia. 
Endometriosis is a severe complication after abortion.  
The normal endometrium (inner functionally active layer) lines the 
uterus and is torn away from each menstruation. For injuries of the 
uterus endometrial particles begin to “grow” into the muscle layer. 
This leads to the development of endometriosis. Almost half of these 
patients develop infertility. 
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Carrying out an abortion in a woman with Rh negative is a factor 
especially at the first pregnancy, resulting in rhesus conflict, the result 
of this woman’s inability to bear the subsequent pregnancy. 
There are also psychological effects of abortion. In our country, 
they are very poorly understood. Psychologists point out that post-
abortion depression and feelings of guilt are developed in women, 
which are independent of the social environment in which the woman 
resides. It was also observed in non-Christian countries, such as Japan, 
where, after the legalization of abortion there was established children 
church where women could bring figurines, dolls, which symbolize 
their aborted children. Thus, they brought a kind of sacrifice and that 
was expressed repentance. 
After an abortion, a woman is aware of the guilt associated with 
the loss of sense of her own usefulness. It should be noted,  
by killing a child a woman destroys something big that would be the 
goal of her life.  
This leads to the destruction of basic trust between spouses and 
later, to the rupture of family relations. More often, it leads to the end 
of extra-marital relations. 
In such cases, there is no sense of gratitude, of the familiar to the 
patient with respect to his surgeon after curative surgery, but instead 
it leads to the resentment and anger. A patient whose doctor refused to 
carry out an abortion would never have claim to it, but rather thank for 
saving a child. 
How can the ethical position protect a doctor? What are the goals 
of medical and health activities? 
To help a person overcome the disease, or at least alleviate the 
suffering of the patient in the case of abortion, neither one nor the other 
chains are not achieved because the pregnancy is not a disease. During 
an abortion one of the two patients is injured, we talked about 
(physically and mentally), and the other is dead. 
For many women, it is enough to see her child on an ultrasound 
monitor screen and listen to the beating of its heart to abandon the 
abortion decision. Contrary to current thinking, the abortion rate is not 
related to economic factors (the link between material wellbeing of the 
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family and abortions cannot be traced). In contrast, in poor countries, 
families are large and wealthy families tend to fewer children. 
Medical and ethical evaluation of abortion 
The point of view of experts who are against abortions is 
consistent with the text of the Hippocratic Oath (V–IV century BCE), 
which contains the following: “I’ll never give a woman an abortive 
means”. 
Let’s compare domestic ethical standards with international 
ones. We turn to the Declaration “On the medical abortion” (adopted 
by the General Assembly of the World Medical Association in 
September 1948, supplemented by the 35th Assembly in October 
1985.) The Declaration proclaims the principle “respect for human life 
from the moment of conception” as the basic moral principle of doctor. 
The right to refuse medical abortion 
Ukrainian legislation does not provide for the right of a 
physician to refuse abortion. Indeed the right to refuse medical 
“assessment and treatment” of a patient can be realized only if adhered  
to the following grounds. 
First, such a refusal is admissible only if the patient does not 
comply with the orders and regulations of the therapeutic or 
prophylactic institutions. 
Second, the failure of examination by a physician and treatment 
of the patient, must not threaten the patient’s life and the health of 
others. 
Obviously, the reluctance of doctors to search through a life that 
is born, fits into the framework outlined by the law out of 
“investigation and treatment of the patient”. In the case of abortion, it 
is not about “treating” a patient and a medical intervention, the 
possibility of failure on the part of the doctor when is not regulated by 
existing provisions. 
In this case, we refer to the specific regulations of the existing 
world. In particular, the right to refuse medical abortion is enshrined 
in paragraph 6 of the Declaration of the World Medical Association 
“The medical abortion” (Oslo, August 1983), according to which, if 
personal beliefs do not allow the doctor to make medical abortion, he 
should entrust the patient to a competent colleague. 
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There are different abortion laws in certain countries of the 
world according to the degree of severety. 
The most liberal laws are envisaged in countries where abortion 
is permitted for a woman’s request: 
a) former socialist states, the Scandinavian countries (abortion 
is permitted in the first 3 months of pregnancy); 
b) Sweden (abortion is permitted in the first 18 weeks of 
pregnancy); 
c) Denmark (abortion is permitted in the first 21 weeks of 
pregnancy); 
d) US (abortion is permitted in the first 24 weeks of pregnancy); 
e) Tunis and Singapore (there are no restrictions to abortion). 
The most severe laws are provided in countries where abortion 
is permitted only on a limited range of medical and genetic evidence: 
Belgium, Ireland, Italy, Luxembourg, Malta, Monaco, Portugal, 
Albania, Brazil, Colombia, El Salvador, Uruguay, Bangladesh, 
Indonesia, the Philippines, Algeria, Kenya, Nigeria, Morocco, New 
Zealand, Fiji. 
The appearance of the embryo at different stages of embryonic 
development is presented below (fig. 2.1). 
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Five and a half weeks 
The length of the embryo is 10–12 mm. 
Eyes are clearly defined by dark circles. 
The ending has developed into a small 
hand. Blood with oxygen and nutrients is 
supplied to the embryo through the 
umbilical cord 
 
Six weeks 
The embrio is already starting to move as 
much as 12 weeks earlier than the time 
when the mother feels the movements. 
Embrio’s heart beats at a frequency of 
140–150 beats per minute, twice as much 
as by mother 
 
Eleven weeks 
Fetus’ weight is about 30 grams, length is 
6 cm. The heart starts beating at 18–
25 days. The little creature can pucker, 
change facial expressions and even smile. 
All body systems are improved 
 
Figure 2.1 – The appearance of the embryo at different stages  
of embryonic development 
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Twelve weeks 
Fetus is well “settled” in the uterus, brain 
and nervous system begin to play an 
important role. Three-month-old fetus is 
like a newcomer in the universe, 
“astronaut” in a special capsule with a 
leash, which supplies everything 
necessary for life and development. In 
most cases, the mother may serenely move 
 
Sixteen weeks 
11–15 week fetus grows every month by 
5–15 cm. It already knows how to grasp 
something with hands, swim and even roll 
 
Eighteen weeks 
The length of the fetus reaches 20 cm. 
Look at the handle, a true work of art. 
Thumb is already well developed, the 
fetus is able to suck it. It becomes active 
and energetic; straining muscles, pushes 
arms and legs. Now its mother feels 
movement 
 
Figure 2.1, continuation 
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2.2 Euthanasia: ethical and legal issues 
Euthanasia is an easy, painless death that occurs as a result of 
certain actions of man in relation to himself, or as a result of certain 
actions by other persons acting solely at the request of a person who 
by reason of his own physical disability, needs their help.  
Exception: if a person, who has critically ill physical condition, 
doomed to a slow death, is not able to express his will, the actions of 
the people, who take in such a case the responsibility for decision-
making in respect of such person, may also be considered euthanasia, 
when it was decided.  
It should also be recalled that the above-mentioned exclusion is 
the most problematic aspect in the issue of euthanasia, and that the 
exception should be made for the determination of euthanasia, since 
the category of people who are physically unable to express their will, 
can not at least need to be euthanized than those who are physically 
able to ask for euthanasia. Category of terminally ill people 
experiencing physical pain and mental suffering, who are not able to 
know physically that they need to be euthanized, only on the basis of 
physical disability the right to euthanasia is denied, this means that 
such legislation does not protect the person, but dooms him to a slow 
painful death. 
Problem of euthanasia begins its chronology in ancient times. 
And even then it caused much controversy among physicians, lawyers, 
sociologists, psychologists. English philosopher Francis Bacon 
(1561–1626) coined the term “euthanasia” (from Greek euthanasia, eu 
is good, thanatos is death) i. e. a good, quiet and easy death, without 
pain and suffering to refer an easy painless death.  
Types of euthanasia  
In theory, there are two types of euthanasia: passive euthanasia 
(the intentional termination of the patient’s medical maintenance 
therapy) and active euthanasia (administering medications for dying 
or other actions that result in a quick and painless death). Active 
euthanasia is often classified as suicide with medical assistance 
(provision of the patient at the request of drugs that reduce life).  
Active euthanasia is the implementation of actions to accelerate 
the death of a man, according to his own decision. Also active 
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euthanasia can be called actions of the person to accelerate his own 
death. For example, a special organization (and the only such 
organization is “Dinite” in Switzerland) provides an apparatus which 
is set in motion by the person in need of euthanasia.  
Active euthanasia at the legislative level is only allowed in three 
European countries: Belgium, the Netherlands and Luxembourg. Also 
active euthanasia is allowed in Oregon and Washington of the USA. 
And in fact, euthanasia is permitted in Switzerland, that is officially 
euthanasia is prohibited by law, but Swiss law permits to assist in the 
implementation of suicide. 
In addition, it is necessary to distinguish between voluntary and 
involuntary euthanasia. 
Voluntary euthanasia is carried out at the request of the patient 
or a previously expressed consent (for example, in the United States a 
common practice in advance and in a legally valid form of expressing 
their will in the event of irreversible coma).  
Involuntary euthanasia is carried out without the consent of the 
patient, as a rule, is unconscious. It is made on the basis of the decision 
of relatives, guardians, etc. Council on Ethics and Judicial Affairs of 
the American Medical Association in this case admits that these 
decisions may be “unfounded”. However, in the case of a “competent 
decisions”, it is believed that people have the right to make decisions 
that others feel foolish, because their choice of passes through the 
competence based process and is compatible with their personal 
values. 
Passive euthanasia is to stop any action to sustain human life, 
provided that the person himself made the decision (such as turning 
off the respirator).  
“For example, we can get the situation with the patient a hundred 
years ago. In the XIX century, hopelessly sick would just quietly die, 
giving soul to the Lord, and now he would be breathing through a 
respirator, heart would beat through the apparatus of the artificial 
heart, the kidneys have to work with the appropriate unit, etc. And 
outside the intensive care unit physicians would argue what to do with 
him then” (Prof. Gorovsky). 
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Passive euthanasia is permitted in more than 40 countries around 
the world.  
The difference between active and passive euthanasia.  
American philosophers, analyzing the difference between active 
and passive euthanasia, state: “An important difference between active 
and passive euthanasia is that in passive euthanasia the doctor does 
nothing, and the patient dies because some disease has struck him. 
With active euthanasia the doctor does something that leads to death 
of the patient, i. e., he kills him. Physician who makes a lethal injection 
to a cancer patient causes the death of this patient, but if it’s just to 
stop treatment, the cause of death will be cancer”. 
Declaration on the treatment of terminally ill patients  
suffering from chronic pain 
Treatment of terminally ill patients suffering from chronic pain, 
should be carried out so that they can die with dignity. Proper use of 
opioid and non-opioid analgesics may relieve the suffering of the 
majority of terminally ill people. Doctor and all involved in the 
treatment of patients suffering from the pain of the dying are obliged 
to adequately represent the genesis of pain a patient experiences, know 
the clinical pharmacology of analgesics, to understand the needs of the 
patient, his family and friends. The Government is obliged to ensure 
the availability of such a large number of opioids, which are necessary 
for the adequate management of severe chronic pain. 
Principles of the clinical management of severe chronic pain 
The physician should focus on alleviating the suffering of the 
terminally ill patient. The pain experienced by this patient, is only one 
part of his misery. The degree of pain can range from tolerable to 
unbearable. 
There is a difference between acute and chronic pain; it dictates 
the use of a particular opioid analgesic. The following are the general 
principles of the analgesic benefit in severe chronic pain. 
1. Treatment should be individualized so that both can 
adequately meet the needs of the patient and to maintain, as much as 
possible, the state of comfort. 
2. It must be remembered that the tolerance of chronic pain is 
different from acute pain tolerance. 
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3. In order to rid the patient of the pain a physician must know 
the strength, duration and side-effects of available analgesics, choose 
the appropriate, to determine the dose and dosage regimen. 
4. To the patients who are not helped by non-opioid analgesics, 
a combination of non-opioid analgesics and opioid may produce a 
marked effect. 
5. The loss of analgesic effect because of the patient’s addiction 
to the drug dictates replacement analgesic. 
6. The emergence of iatrogenic dependence on the drug should 
not be seen as a major problem in the treatment of severe pain on the 
background of neoplastic diseases and cannot be grounds for rejection 
of the use of strong analgesics in patients whom analgesics may help. 
Venice Declaration on Terminal state 
1. During the treatment the doctor must, if possible, ease the 
suffering of the patient, guiding by his interests. 
2. Exceptions to the above are not allowed, even in the case of 
incurable diseases and deformities. 
3. Exceptions to the above principle, without considering the 
following cases: 
a) the doctor does not extend the agony of the dying, stopping 
at his request, and if the patient is unconscious – at the request of his 
relatives, the treatment that can only delay the onset of the inevitable 
end. Refusal of treatment does not relieve the physician from the 
obligation to help the dying, assigning drugs to alleviate the suffering; 
b) the physician must refrain from the use of non-standard 
methods of treatment, which, in his opinion, will not have any real 
benefit to the patient. 
The doctor can artificially sustain the life of the deceased 
functions in order to preserve his organs for transplantation, provided 
that the country’s laws do not prohibit this, there is consent given 
before a terminal condition by the patient, or after ascertaining the fact 
of death, his legal representative and death pronounced doctor right 
not associated with the treatment of the deceased, nor with the 
treatment of the intended recipient. Doctors assisting the dying, should 
not depend on the potential of the recipient, or by treating his doctors. 
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2.3 Transplantology 
Transplantation is the transfer (engraftment) of human cells, 
tissues or organs from a donor to a recipient with the aim of restoring 
function(s) in the body. 
There are four main types of transplantation: 
1. Autotransplantation (autologous transplantation) – recipient 
of a donor graft is for himself. 
2. Izotransplantation (homologous transplantation) – donor 
transplant is 100 % genetically identical to the recipient and 
immunologically identical twins recipient. 
3. Alotransplantation (heterologous transplantation) – donor 
transplant is an organism of the same species, but genetically and 
immunologically different from the recipient. 
4. Xenotransplantation (interspecies transplantation) – organ 
transplantation from another species than people (e. g. pets). 
Although the idea of organ transplantation is an old one, 
successful transplantation did not occur until the twentieth century. 
Today the transplantation of many organs between well-matched 
human beings is quite successful, with the majority of recipients living 
five or more years. Kidney, cornea, bone marrow and skin transplants 
today, for example, are considered routine for certain conditions. Heart 
and lung or heart-lung transplants, liver and pancreas transplants are 
also becoming more common.  
The ethical and legal issues related to organ and tissue 
procurement and transplantation are often discussed in light of such 
principles as autonomy, benevolence, non-maleficence, free and 
informed consent, respecting the dignity, integrity and equality of 
human beings, fairness, and the common good.  
Transplants between living persons raise the question whether it 
can ever be ethical to mutilate one living person to benefit another. 
Concerning this many distinguish between parts of the body that can 
regenerate (e. g. blood and bone marrow) and parts that do not 
regenerate. Regarding the latter some are paired (e. g. kidneys, corneas 
and lungs), whereas others are not (e. g. heart). A competent adult can 
give free and informed consent to be or not to be a living donor, but 
an incompetent person cannot. Can a guardian ethically consent for a 
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legally incompetent person, such as a severely mentally disabled adult 
or a minor, to be a living donor? Regarding medical decisions an 
incompetent person’s guardian is to act for their benefit or best 
interests, and, as far as possible, their wishes, if known and reasonable.  
Ethical Issues Regarding the Recipient 
Nobody (i. e. no potential recipient) has a claim on organs or 
tissue of any person, living or dead. The sick should thus accept the 
tissue and organs freely offered by others as a gift. This position is 
widely accepted. 
Another moral issue involving the recipient is free and informed 
consent. A competent person who could possibly benefit from 
receiving a transplant should be adequately informed regarding the 
expected benefits, risks, burdens and costs of the transplant and 
aftercare, and of other possible alternatives. So should the guardian(s) 
of an incompetent person. A legally incompetent person who can 
understand some things that are relevant to their condition, a proposed 
transplant, and decisions that they are capable of making, should be 
informed of these in an appropriate way. Guardians should respect the 
wishes, if known and reasonable, of incompetent persons in their care. 
Proper safety measures should be followed to protect transplant 
recipients from receiving AIDS and hepatitis viruses, etc. 
The main ethical issues in transplantation can be grouped into 
blocks: 
1. The first block of the ethical problems is associated with the 
commercial relations during transplantologic operations. 
2. The second block is problems related to statement of a 
person’s death and the criteria for brain death. 
3. The third block is transplantation (deletion) bodies and (or) 
tissue from a living donor or a cadaver.  
The problem of transplantation commercialization 
It is known that the purchase and sale of organs is prohibited by 
international and Ukrainian legislation. The prohibition of buying and 
selling humans also applies to the organs and tissues. 
The ethical principles that limit the commercialization of 
transplantation, are a kind of “hurdles” in the way of possible dangers. 
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This is the task of the ethical principles governing the diagnosis “brain 
death”. 
Ethical issues related to ascertaining death on criteria of 
brain death 
Historical criteria of a person’s death is the lack of independent 
work of two body systems: respiratory and cardiovascular. Today, the 
traditional, historical criteria added one that is the “brain death”. 
The criterion of “brain death” was formed gradually. In 1959, 
French neurologists P. and M. Molar Gulon described the state of 
otherworldly coma, in 1968 criteria of brain death were developed at 
Harvard. The Declaration of Sydney have been confirmed and 
clarified the same year.  
The concept of “brain death” is based on an understanding of a 
person’s death: the death of a man is irreversible degradation and (or) 
the dysfunction of critical body systems, i. e. systems, essential 
artificial, biological, chemical or electronic technology systems, not 
just the brain is fungible. 
The concept of “brain death” and “biological death” are mixed 
not rarely. It is important to say that, although the criterion of brain 
death is accepted in medicine, but in society, it clearly does not 
perceive. This is due to the traditional views of people about the heart 
as the heart of a man. 
Types of Consent (Voluntary or Expressed, Family, 
Presumed, Required Request, Routine Inquiry) 
Voluntary or expressed consent involves a person making 
known free offer to donate one or more of his organs and/or bodily 
tissue, after person has died or while alive. Concerning cadaver 
donation, a person can express his wishes by some form of advanced 
directives, such as by filling out the Universal Donor Card attached to 
their driver’s license. Free and informed consent is required when 
the transplantation is from a living donor. Previously expressed 
voluntary consent regarding a deceased donor is the ideal because it 
involves an act of love and responsible stewardship over one’s body. 
It also communicates to others, including one’s family and health care 
professionals, one’s wishes.  
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Many potential organs and tissues for transplantation (e. g. of 
brain-dead accident victims) are lost because the people did not 
previously express voluntary consent and their families were not 
approached about donating. Because of this and the shortage of organs 
and tissues for transplantation, some have proposed other models of 
consent including presumed, required request and routine inquiry, to 
hopefully increase the supply. Although only a minority of deceased 
potential donors have signed donor cards, surveys show that most 
people favor organ donation. Some argue that it is ethical to presume 
consent on their behalf, unless the person while alive gave clear 
indications to the contrary, since a transplant does not harm the donor 
after death and it can benefit others. 
Required request stipulates hospitals to develop protocols to 
ensure that families of potential donors are actually asked to donate.  
Routine inquiry requires hospitals to develop protocols to 
ensure that families of undeclared potential donors have the 
opportunity to donate, people tend to react more positively when 
offered a choice. Some have criticized these approaches as not 
allowing professional discretion. 
The Law Reform Commission of Canada recommends 
maintaining and strengthening the present express consent model in 
Canada with hospitals implementing routine-inquiry protocols. These, 
however, are to recognize professional discretion not to ask in cases 
where this would clearly be inappropriate.  
There are three main types of legal regulation of organs removal 
from a deceased person: 
1. Standard withdrawal. 
2. The presumption of consent. 
3. The principle of the presumption of dissent. 
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The essence of the principle of routine sampling is that the body 
after death becomes the property of the state. This means taking a 
decision to exclude bodies taken in the interests of the state’s needs. 
Routine removal has lost its legitimacy in modern society 
because, saying more precisely, there are two basic principles: 
1. Presumption of consent. 
2. Presumption of dissent. 
Presumed consent is valid in Russia, Austria, Belgium, Spain, 
the Czech Republic and Hungary, and other countries. 
Presumption of disagreement (or dissent) is enshrined in law 
of the United States, Germany, Canada, France, Portugal, the 
Netherlands.  
The presumption of consent, also known as “supposed consent” 
and “model of objections”. This is largely due to the fact that the 
principle of “presumed consent” is not only positive but also has 
negative aspects: 
1. The most important condition for the realization of human 
rights or relatives to refuse the removal of organs is a full informing 
the public about the nature of their rights and the consequences of their 
refusal. Most people do not know the mechanisms of in vivo clearance 
of failure. 
2. The downside of this principle is that it forces the doctor to 
make, in effect, acts of violence to person or property, without consent. 
In ethics, this is qualified as “violence”. 
The positive side of “presumed consent” is solely to increase the 
number of organ transplants. This is because the authorities confiscate 
organs from those who expressed no opinion on that. This principle 
significantly simplifies the procedure for obtaining organs for 
physicians, because they do not need to obtain consent from relatives. 
Paired organs, such as kidneys, are generally used, or a part  
of an organ (liver and others) is taken. 
Exclusion of organs and tissues from a living donor for a 
transplant is the subject to the following conditions: 
– if the donors voluntarily and knowingly agreed in writing to 
withdraw their organs or tissues; 
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– if the donor is warned about possible complications to his 
health due to surgery for removal of organs or tissues; 
– if the donor has passed a comprehensive medical examination 
by specialists about the possibility of withdrawal of his organs or 
tissues for transplantation. 
Ethical Issues Regarding Allocation of Limited Resources. 
Criteria for Selection 
Requests or the demand for human organs and tissues usually 
exceed what is available or the supply. Significant practical and ethical 
questions regarding efficiency and fairness arise as to how to distribute 
best these limited resources. On what basis should this person rather 
than that one be chosen to receive a given organ? Who should choose? 
These decisions are serious as they can involve results about who will 
live and who will die. A widely used and approved criterion of 
selection is to give priority to those who have a great need and are 
expected to benefit greatly. For example, it does not make sense to 
give a limited number of available organs to those who will not benefit 
or are expected to only live marginally longer but suffer much with the 
transplants, when others would benefit greatly. While this criterion is 
widely accepted as fair, there is much discussion about how to define 
and assess “benefit”. Many argue that both  
the expected length of survival and the possibilities regarding 
rehabilitation should be considered. 
In spite of the success of transplants, care must be taken not only 
if they extend life biologically, but also offer the patient a real chance 
for a healthy life. The new organs should add new years to life, and 
help to provide a new and better life. 
As a last resort a choice sometimes has to be made between a 
transplant immediately available but with a very small chance of 
survival, and a long term transplant offering a greater possibility of 
healing. 
With regard to who will likely benefit more from receiving a 
transplant, medical criteria such as blood and tissue typing (i. e. who 
is less likely to reject the transplant), and the absence of other life-
threatening diseases, are used. Other factors such as the potential 
recipient’s will to live, motivation and ability to follow post-operative 
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directions (e. g. taking immunosuppressants), his or her family 
support, and the skill of the transplant team can also be relevant to the 
success of a transplant. 
Criteria for allocation of donor organs and (or) tissues 
The fourth block of the ethical problems is associated with the 
early stage of the distribution of available donor organs in accordance 
with accepted international principles main criterion that influences 
the decision of the doctor. Immunological and biological data of the 
person who needs an organ transplant, are entered into the database, 
that is “waiting list”. Waiting queues exist at different levels, for 
example, in large cities, at the regional and even national level. 
On the other hand, there is a database of donor organs and 
immunological parameters. If the biological data of the donor organ 
fit to the biological parameters of the person who is in the “waiting 
list” this person will be the recipient and get the necessary organ 
because his body is most compatible to donor. This principle of 
distribution is considered to be the most fair and fully justified from a 
medical point of view, as it helps reduce the reliability of rejection of 
the organ. 
If there are more than one suitable donor organ recipient from 
the list, in this case it comes into action the second criterion is the 
criterion of severity of the recipient. Under the condition of one 
recipient  he can expect six months or a year, and another can expect 
no more than a week or a month. The organ is given to those who 
cannot wait long. 
However, how to be in a situation if two recipients of organ are 
almost equally suitable, and they both are in critical condition and 
cannot wait long? In this case, the decision is made on the basis of the 
criterion of priority (third criterion). The physician should consider 
the length of stay of the recipient in the “waiting list”. Preference is 
given to someone who used to be written in the “waiting list”. 
In addition distance is also taken into account to these three 
criteria, i. e. the distance from the location of the recipient to the donor 
organ. Body with the smallest period for a heart transplant, about five 
hours. And if the time spent on overcoming the distance between the 
body and the recipient of more time “life” of the body, the donor organ 
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is given to the recipient, which is at a close distance. Consequently, 
the main criteria for the division of donor organs as they are of 
importance: first, the main, is the degree of immunological 
compatibility of donor–recipient pairs, the second is the severity of the 
recipient, and the third is sequence. 
Additional ethical issues that arise in the allocation of donor 
organs and tissues. Now many candidates are denied transplants. The 
forecast for candidates with vascular disease are less optimistic, so 
these patients are not included in the list for an organ transplant. 
There is a list of the basic ethical principles governing organ 
transplants or tissues. 
1. Human organs cannot be regarded as an object of sale. 
Declaration of the World Medical Association declares: “The 
purchase and sale of human organs is strictly forbidden by the Law of 
Ukraine “On the transplantation of organs and (or) tissues”. Health 
care organizations are allowed to conduct organ retrieval operations 
on bodies (or tissues) of a corpse, and selling is prohibited. 
2. Transplant from a living donor can only be based on sacrifice 
to save the life of another person. This consent for organ removal is a 
manifestation of love and compassion. 
3. A potential donor must be fully informed of the possible 
consequences of organ transplantation for his health. 
4. Transplantation, which directly threatens the life of the donor, 
is not morally permissible. According to the Ukrainian law, organ 
removal from a living donor is permitted only if the donor is a recipient 
of a genetic link with the exception of cases of bone marrow 
transplantation. 
5. An unacceptable reduction in the life of one man in particular 
through the refusal of life-supporting treatment to lengthen the life of 
another. 
6. The most common practice is the removal of an organ of a 
newly deceased people. There should be eliminated uncertainty as to 
the time of death. 
7. There are the following three principles of Terms and 
Conditions of ethically correct diagnosis of “brain death”: the 
principle of a single approach, the principle of collegiality and the 
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principle of financial and organizational independence of the 
Brigades. 
8. The priority of the division of donor organs should not be 
determined by the identified strengths of individual groups and special 
financing. 
9. Three criteria are taken into account in the fission of donor 
organs: the immunological compatibility of donor-recipient pairs, 
severity and priority recipient.  
 
2.4 Genetic reproductive technologies: ethicality  
and legality 
Surrogacy is the term used when a woman bears a child for 
another woman. The usual indications for this are that the woman 
cannot bear the child because the uterus is absent or malformed or 
when a medical condition exists making pregnancy a threat to her 
and/or her baby’s health. 
Natural surrogacy is when a healthy woman with normal 
ovaries, tubes and uterus is inseminated with sperm from the husband 
of a woman who is unable to carry a baby. If the surrogate woman 
becomes pregnant and has the baby, then the woman who cannot have 
the baby and her husband with whom she was originally inseminated 
adopt the baby. It is unethical for Fertility Associates to assist with 
natural surrogacy, such as by undertaking the insemination, without 
prior Ethics Committee on Assisted Reproductive Technology 
(ECART) approval. 
In vitro fertilization (IVF) surrogacy is when the woman who is 
unable to bear the child has normal ovaries but is still unable to bear a 
child, undergoes IVF hormone stimulation and egg pick-up (Oocyte 
pick-up – OPU), with fertilisation of the eggs by her husband’s sperm. 
Then their embryos are transferred to the surrogate. The surrogate 
must be healthy, have a low risk for complications during any 
pregnancy that occurs and be willing, after delivery, to give the baby 
to the genetic parents from whose egg and sperm it was conceived. 
The ethical and legal issues associated with surrogacy are not 
simple. The Ethics Committee on Assisted Reproductive Technology 
(ECART) requires Fertility Associates to make an application in one 
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or two stages. Considerable consultation and counselling is usually 
required before the application can be made. Fertility Associates is 
very supportive of IVF surrogacy when the woman who would carry 
the baby is a family member or a close personal friend of the couple 
who need surrogacy, especially if they have completed their family. In 
the sphere of surrogacy, Ukrainian legislators have proven to be far 
more progressive than many of their European colleagues. Today, 
Ukraine is one of the very few surrogacy friendly countries in Europe. 
Unlike other nations that limit or even ban surrogacy, in Ukraine the 
intended parents of child are considered to be biological parents from 
the moment of conception, and they are specifically named as 
biological parents in the birth certificate without any mentioning of 
surrogate mother. 
Importantly, the surrogate cannot legally keep the child after the 
birth. On the contrary: the child is considered to legally belong to the 
prospective parents from the very moment of conception. In fact, in 
the legal history of Ukraine, there has not been a single reported case 
of a disputed custody claim arising over a surrogate parenting 
arrangement or the validity of a surrogacy agreement. In sharp 
contrast, the laws in several U. S. states (and in Russian Federation) 
allow a surrogate mother to keep the child after its birth, regardless of 
the agreements between the intended parents and surrogate mother.  
Applicable legislation. In general, applicable Ukrainian 
legislation lacks almost all prohibitions that are commonly found in 
other European countries, and offers the following advantages:   
a) no limits on surrogacy related payments; 
b) no additional legal procedures to obtain court order; 
c) no adoption of your own child is required; 
d) Ukrainian law allows to issue birth certificate to intended 
parents’ names regardless of their genetic links to the child;  
e) donor or a surrogate mother has no parental rights over the 
child, who is legally the child of the prospective parents from the 
moment of conception. 
Agreements. Various agreements have to be signed between the 
parties, including contracts with (a) the medical institution responsible 
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for insemination and further medical surveillance, (b) the surrogate 
mother and (c) surrogacy agency (if any). 
Gestational surrogacy agreement is an indispensable tool. It is 
also one of the most difficult agreements to negotiate and draft. 
Unfortunately, Ukrainian legislation does not provide any useful 
guidance, leaving the parties to their own devices in addressing the 
key issues. As a result, surrogacy agreements are usually “self-
contained,” highly complicated documents, reflecting many 
contingencies. These agreements are enforceable legal documents that 
will regulate the relations between surrogate mother and the intended 
(genetic) couple. 
The surrogacy agreement must be in writing and signed before 
a notary prior to the embryo transfer. At a bare minimum, the 
following issues should be addressed: surrogate mother’s health 
status; conditions which surrogate mother should observe; medical 
institution where the procedure will be performed; surrogate mother’s 
remuneration, additional expenses, timing of payment(s); expenses 
connected with impregnation, pregnancy, act of delivery and 
registration of child; procedure of child transfer and registration; any 
force majeure provisions, including the delivery of handicapped child, 
delivery of more than one child, delivery of dead child, delivery 
complications resulting in surrogate mother’s future infertility; 
confidentiality provisions and non-disclosure of information to the 
child or any third party, etc. 
Since the Ukrainian Family Code presumes that genetic parents 
of the child born by a surrogacy will be a married couple, a Ukrainian 
notary will need to see a marriage certificate of the genetic parents, 
notarized and apostilled (in the USA at your home state department), 
translated and translation must be notarized.  
Birth Certificate. Pursuant to the Ukrainian Rules for Statistic 
Registration, dated 18.10.2000, foreigner citizens may apply for a 
birth registration to the Ukrainian Vital Statistics Office. They have to 
submit a medical certificate that proves their genetic relationship to a 
child and the surrogate’s written consent to record their names on the 
birth certificate of the child she delivered. The names of the intended 
(genetic) parents are written in the birth certificate upon the child’s 
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birth. There is no need to get any special permits from any committee, 
court or other institution. No adoption procedure is required.   
In conclusion, today’s options for family formation extend 
beyond adoption. Advances in medical science offer intended parents 
a number of new pathways to parenthood. Some of these paths, such 
as sperm donation and traditional surrogacy, have long been in 
existence. Other procedures, such as egg donation, embryo transfer, 
and gestational surrogacy, are more recent developments in the field. 
 
Questions for Self-checking 
1. What are the main slogans of Pro-life and Pro-choice 
movements? 
2. List the types of euthanasia. 
3. In what countries the technology of surrogacy is illegal? 
4. Criteria for allocation of donor organs and (or) tissues. 
5. Presumed consent and dissent in transplantology. 
6. Harm effect on women’s health after and during abortion. 
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Topic 3. Bioethical aspects of experiment and clinical 
research. Bioethical committees: models, rights and obligations 
Main lecture questions:  
3.1 Eugenics: legal and bioethical issues 
3.2 Organization of a scientific experiment in compliance  
with the basic principles of bioethics 
3.3 Bioethical committees: models, rights and obligations 
3.4 Clinical trials and evidence-based medicine 
 
3.1 Eugenics: legal and bioethical issues 
Eugenic considerations are not specific to behavioral genetics, 
though they are certainly germane. Whether and how behavioral 
genetics findings may be used to achieve eugenic goals is the subject 
of ongoing discussion and debate (e. g., Nuffield Council on Bioethics, 
2002). The eugenics movement was founded by Sir Francis Galton in 
England in the 1860s. Eugenic means ‘‘well-born’’. Inspired by the 
success of plant and animal breeders, Galton wondered whether the 
human race might be similarly improved through a program of 
eugenics: we could, he thought, decrease the number of ‘‘undesirable’’ 
humans and increase the number of ‘‘desirable’’ ones (Galton, 1869).  
Eugenics is usually divided into positive and negative varieties. 
Negative eugenics involves discouraging or preventing those 
deemed unfit from reproducing. Involuntary sterilization is an instance 
of negative eugenics.  
Positive eugenics is the encouragement of those deemed fit to 
reproduce in abundance, and to give birth only to the most perfect 
offspring. Though there was considerable social and scientific support 
for eugenics in the late nineteenth and early twentieth centuries, the 
technologies for achieving positive eugenics were not yet available. It 
is only in the past few decades that some of these technologies (such 
as prenatal and preimplantation diagnostic technologies) have been 
developed. 
Combined with findings in behavioral genetics, and especially 
with creeping medicalization, we may witness increasing social 
pressure to improve humankind by eugenic means. Indeed, some have 
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argued (controversially) that it is morally imperative to use genetic 
selection technologies in support of eugenic enhancement. 
Eugenics (from the Greek “noble”, “the good kind”) was created 
by Francis Galton, and rising to the Platon’s “State” doctrine of the 
conditions under which the offspring is born, good for your physical 
and spiritual attributes, and prevented the birth of a failed generation. 
For the first time this term has sounded in the book of the English 
biologist F. Galton “Heredity talent, its laws and consequences”, 
published in 1869. F. Galton proposed the theory of the origin of 
hereditary tendencies, abilities and talents. 
The author argued that the conscience, dignity and other 
manifestations of human higher mental abilities are biologically 
predetermined. 
The purpose of this was to improve the teaching of “human 
nature” in the early stages by preventing possible deterioration of his 
hereditary qualities in the future through the creation and development 
of methods to facilitate the improvement of human qualities, such as 
the availability of health, mental ability, talent. 
The program of the physical destruction of the mentally ill 
during the Third Reich in Germany included a series of sequential 
steps: 
1) sterilization of people sicked on schizophrenia, cyclothymia, 
hereditary epilepsy, hereditary blindness and deafness, alcoholism, 
mental retardation; 
2) destruction of children with physical and mental disabilities; 
3) action of “T4” had gradually completed physical destruction 
of adult psychiatric patients by 1945. 
Dachau was the first concentration camp of Nazi Germany. 
Created in 1933, immediately after Hitler came to power, to eliminate 
dissidents. Later, there were carried out medical experiments “in order 
to preserve the purity of Aryan blood”. 
By the beginning of the war Dachau camp was a perfectly well-
adjusted factory killings, torture and experiments on humans with 125 
offices. 
During the existence of the camp to 250 thousand people passed 
through it from 24 countries, 70 thousand of which were brutally 
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tortured and killed, 140 thousand survivors of the “experiments” were 
transferred to other concentration camps in Germany and only 20 
thousand survived until liberation. 
The Nuremberg Code. The Nuremberg Code was developed 
during the Nuremberg trials, which is the first international document 
containing a list of ethical and legal principles of studies on people. 
These documents were the main arguments of the prosecution at 
the trial in Nuremberg of the German doctors, guards and the camp 
commander. 
The Nuremberg Code was prepared by participating in the 
process of US experts – physicians – Leo Alexander, Andrew Ivy, and 
has become an integral part of the decision of a court. 
During the Nuremberg trials of Nazi war criminals, scientists 
and doctors announced the evidence of experiments conducted on 
concentration camp prisoners. Particularly cruel, inhuman nature of 
the experiments was the fact that they actually planned the death of 
subjects. 
Helsinki–Tokyo Declaration of 1964–1975. It was adopted by 
the 18th World Medical Assembly in Helsinki (Finland) in 1964 and 
revised by the 29th World Medical Assembly in Tokyo (Japan) in 
1975. 
International Code of Medical Ethics. Adopted by the third 
General Assembly of the World Medical Association, London, UK, in 
October 1949, supplemented by the 22nd World Medical Assembly, 
Sydney, Australia, in August 1968 and the 35th World Medical 
Assembly, Venice, Italy, in October 1983. 
Declaration on the Protection of Patients’ Rights in Europe 
1994. Source: Regional Office for Europe of the World Health 
Organization with the participation of the Legislation Division of the 
Amsterdam University of Health, 1994. May 6, 1994. 
Council of Europe Convention of 1991. Adopted by the 
Council of Europe Convention is intended to serve as a guide for the 
protection of human rights and dignity in the field of biomedical 
science and practice. 
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The Convention on the protection of human rights and dignity 
in relation to the Application of Biology and Medicine of the United 
Nations (Convention on Human Rights and Biomedicine). 
 
3.2 Organization of a scientific experiment in compliance 
with the basic principles of bioethics 
Basic ethical principles of biomedical experiments on animals 
are formulated by the International Council of Medical Learned 
Societies (CIOMS) in the Code of Ethics (1985), includes a section 
“International recommendations for biomedical research using 
animals” and the Declaration of Helsinki of the World Medical 
Association (2000). In these documents, the humane treatment of 
experimental animals proclaimed moral obligation of scientists. It is 
recognized that the use of animals for scientific purposes is not 
desirable and should be possible to apply methods that do not require 
the use of animals, but at the current level of knowledge of the use of 
animals is inevitable. 
The basic ethical principles: do no harm, and scientific validity 
of the study. This means that the experimenter should strive as much 
as possible not to cause animals pain and inconvenience, to be 
responsible for their situation and living conditions, and design an 
experiment to prove its necessity, seeking alternative ways to obtain 
data without involving live animals. 
The criteria of need to use laboratory animals for scientific and 
educational purposes, and in this case are: 
 perform basic scientific research that requires experimental 
verification; 
 a pilot phase of preclinical testing, designed to produce 
results, not attainable by other means (developing new or improving 
existing treatments, the development of technology and the acquisition 
of knowledge for the development of new effective treatment, 
diagnosis or determine the etiology and pathogenesis of the disease); 
 training the technique of urgent surgical interventions, 
mastering the skills and abilities necessary for further work in the 
clinic, the acquisition of which cannot be achieved by other means. 
49 
At the international level the legal basis for the legislative 
regulation of animal experiments is the European Convention for the 
Protection of Vertebrate Animals used for Experimental and other 
Scientific Purposes (number 123, 1986), which includes the main 
provisions of the Code of Ethics CIOMS. EU Council Directive “On 
the approximation of laws, regulations and administrative provisions 
of the Member States for animal protection issues used for 
Experimental and other Scientific Purposes” identified strategic 
ethical requirements in this regard: 
a) the prohibition of using animal experiments if there is another 
(alternative) scientific method to obtain results; 
b) a requirement to reduce the number of animals used in 
experiments and improvement of experimental techniques to minimize 
the suffering of experimental animals; 
c) a requirement competence (appropriate education and skills) of 
individuals who may be allowed to work with animals; 
d) monitoring the implementation of laws by state agencies 
and/or ethics committees of institutions; 
e) periodic reporting, the availability of information on the use of 
experimental animals, and the measures taken for the protection of 
animals used for experimental purposes for the public; 
f) the development of the international system of special 
education for those who work with experimental animals (the 
development of methods of anesthesia and surgical techniques, 
alternatives to animal experiments, familiarity with the laws and 
regulations governing the experiments, and others). 
Since the late 60-ies of the last century the idea of an alternative 
bioassay based on the 3 R was launched and has been steadily 
progressing in practice (Russell & Burch): replace – replace higher 
animals in bioassay invertebrates, cellular and molecular biological 
tests, reduce – reduce the number of higher animals in experiments 
due to better statistical processing of the material, and refine – improve 
the conditions of work with the animals themselves, give the best 
anesthesia to provide quality conditions of detention and sampling of 
biological material. 
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If the execution of the first two points at times is difficult (lack 
of appropriate material and technical base, software, used methods and 
so forth), the improvement of the conditions of work with laboratory 
animals should be made by the experimenter forces. It is necessary to 
ensure the proper use of animals, including the deletion or 
minimization of discomfort, stress and pain when consistent with 
sound scientific work practice. 
The first step is the correct, rational design of experiments in 
which the following steps should be considered: 
a) selection of animal species; 
b) selection of the number of animals and the formation of 
working groups; 
c) conducting an experiment; 
d) removing animals from the experience. 
Regarding the choice of animal species, the importance of this 
stage is determined by the need for further extrapolation –  
the transfer of the data on the person. To date, the whole stage is 
completed screening of species most suitable for carrying out specific 
studies. Thus, it was found that a mouse, a guinea pig, traditionally 
used to study the effects of allergenic chemicals etc., are more 
susceptible to microorganisms and their metabolic products. 
According to the requirements of Good Laboratory Practice 
(GLP) the study of 2–3 animal species is still recommended when 
toxicological evaluation of new chemicals, pharmaceuticals, taking 
into account that the calculated data may not always be verified 
experimentally. This can be due to polymorphism of metabolism,  
e. g., xenobiotics, age and gender-related features. So, there is 
speculation that the list of possible causes of “thalidomide 
catastrophe” one of the places takes non-compliance with the criterion 
of the adequacy of the choice of the type of experimental animal for 
the study of teratogenic effects of this drug. 
Select the number of animals. The unreasonably high number of 
animals is not uncommon in the planning of scientific work. Thus, the 
standard, the optimal group is 7–10 animals, but in some cases, their 
number can be reduced without compromising the reliability of the 
results. This, for example, concerns the assessment of morphological 
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changes in dynamics. Using linear animal experiment must be closer 
to international standards. 
Distribution of animals in groups (depending on the age, sex, 
physiological properties) is also important, determination of the 
amount and test groups, control and reference groups. It is possible to 
reduce the number of experimental animals at this stage through the 
use of laboratory control, of a control group data for several 
experiments conducted in parallel. 
The next stage is directly carrying out an experiment. An 
important role is played by the experimental laboratory equipment, in 
particular, equipment and tools of the operation unit. For example, the 
use of a CSRL BelMAPO operating table, specially designed for 
surgical operations and manipulations on the animals can adjust its 
size (angle of panels tilt to 40°) depending on the size and mass of the 
operated animals and required position for the operation  
(e. g., operating in X-rays office), to lift the distal or proximal part of 
the table, taking into account peculiarities of operations and 
manipulations depending on the diversity of interventions (in the 
lower or upper extremities, chest or abdominal cavities,  
craniotomy, etc.). This provides maximum flexibility for the location 
of the operating personnel, and the optimal surgical approach, which, 
in turn, reduces the duration of surgery, reduces injuries and 
accelerates the subsequent resuscitation. 
During the manipulation, not requiring analgesia or anesthesia, 
you should avoid the use of substances and preparations with severe 
irritating properties. 
All procedures on animals which may cause them pain or any 
other kind of painful state should be carried out with sufficient 
anesthesia (local or general anesthesia). However, taking into account 
that each drug substance causes narcotic effect and a number of 
functional changes in various physiological systems, and these 
changes are not the same type of character. In the formulation of 
experience it is necessary to take into account the peculiarities of each 
drug and to choose the most suitable. In determining the dosage of 
anesthesia, it is necessary to take into account the high sensitivity of a 
52 
number of animal species (birds, some mammals) to these drugs. Even 
a small overdose for many of them can be lethal. 
When you use anesthesia it is prohibited to use funds, preventing 
control of the anesthesia level: tying the muzzle etc. 
Fixation of the animal should only be performed after anesthesia 
will work. Animals should be tied so as not to cause them pain or 
damage, do not disturb the normal circulation, as well as the right not 
to change the position of the muscles or body parts. 
The final stage of the experiment is removing the animal from 
the experience (euthanasia) and sampling of biological material. 
Euthanasia is a quick and painless killing. Dogs, cats and rabbits 
should be subjected to euthanasia only in a state of anesthesia 
(anesthesia overdose: a single dose multiplied by 3). For small animals 
an overdose of anesthesia, permissible quick decapitation are optimal. 
Inhaled anesthetics are desirable (halothane, chloroform). Studies by 
V. V. Rudenko have shown ether use in breeding animals from the 
experiment completely impractical because it distorts the results of the 
experiment, at least on neural tissue. It is unacceptable to use force 
techniques, if the animal is afraid and resists. 
The following methods of killing are prohibited: 
• using muscle relaxants, for pet stops breathing, but feels pain 
and dying, while maintaining consciousness; 
• using electric current, as it may take some time for cardiac and 
central nervous system shutdown, during which the animal feels a 
sharp pain, vocal and motor reactions are absent because of the 
growing paralysis of the muscles; and small animals suffer more 
because they are more resistant to the current; 
• using different kinds of poisons; 
• via painful injections – intravenous, to the heart, pleura; 
• using an air embolism. 
A relationship (ethical, responsible, thoughtful) of  
the experimenter influences not only the life of animals on which 
experiments are carried out, but also the health and lives of the people 
for which they are held. 
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Experimentally-biological clinic (vivarium) is the scientific 
support unit BelMAPO created for keeping and breeding laboratory 
animals used in biomedical research. 
Conducting biomedical research on laboratory animals is 
currently impossible without establishing parity desire to reach by the 
experimenter during the experience as much as possible the amount 
and accuracy of information and respect for the fundamental principles 
of bioethics. 
 
3.3 Bioethical committees: models, rights and obligations 
Ethical (bioethical) committees are a mechanism for ethical 
control over the conduct of biomedical research on humans. 
The provisions of the Nuremberg Code designed during the 
International Military Tribunal are developed and detailed in various 
international and national documents and formed the basis for the 
work on research ethics committees. 
Helsinki–Tokyo Declaration (World Medical Association – 
WMA, 1975) – the term “special committee” was firstly recorded in 
international practice (1964–1975). “The program and the execution 
of each experimental studies in humans should be clearly formulated 
in an experimental protocol which should be submitted to a specially 
appointed independent committee for consideration the remarks and 
proposals” (section 1.2 of the Helsinki–Tokyo Declaration). 
The world’s ethics committees operate on two levels: 
• national; 
• regional (local). 
The main practical work on the ethical control of medical 
science and practice is generally carried out at the regional level. 
There are following models (type) of ethics committees 
according to its functional purpose: 
• the “American” (North American); 
• the “European” model. 
The “American” model is characterized by empowering ethics 
committees “prohibitive” privileges. 
The “European” model is characterized by empowering ethics 
committees “advisory and consultative” authority. 
54 
In the early 70’s, WMA legally documented requirements for 
the composition of the Ethics Committee. 
The composition of the Ethics Committee should consist of at 
least 5 people, including a lawyer and a representative of the so-called 
public, which should ensure the assessment protocol of the proposed 
research, including from the point of view of its social importance. 
The remaining members of the committee should not only be the 
representatives of the institutions, on the basis of which it is supposed 
to carry out research, and should not be representatives of the same 
profession. 
According to international standards (the Helsinki-Tokyo 
Declaration, and others) each research protocol must pass pre ethical 
review and receive approval of the relevant ethics committee. 
The purpose of this examination is to protect the rights, safety, 
well-being and dignity of the people involved in medical-biological 
research and experiments as a test. 
The International Bioethics Committee was established on the 
initiative of UNESCO in 1997. 
The use of medical and biological experiments on humans may 
be subject to the following requirements: 
1) socially useful purpose; 
2) the scientific validity; 
3) the advantages of the possible success of the risk of causing 
serious consequences to the health or life; 
4) the application of the publicity of the experiment; 
5) the full awareness; 
6) the voluntary consent of the person subject of the experiment, 
with respect to their application requirements; 
7) medical confidentiality, where appropriate; 
8) the prohibition of experiments on the legally defined 
categories of persons. 
 
3.4 Clinical trials and evidence-based medicine 
Clinical trials are scientific evaluations of medical interventions 
for the treatment of somatic or psychological conditions that provide 
an analysis of the quality, safety, and efficacy of particular products, 
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or a method of evaluating two products for their comparative value. 
While clinical trials are most often used to test therapeutic 
pharmaceutical products, they can also be utilized to evaluate medical 
devices or surgical procedures, plus other preventive, screening, 
detection, and non-pharmacological therapeutic products/methods. 
Clinical trials influence clinical practice by providing vital 
information to clinicians and patients to use in assessing appropriate 
treatment options. Clinical trials allow for the generation of sound 
empirical evidence that individuals can use to address important 
questions concerning the benefits and harms of particular therapies in 
a scientifically rigorous and ethical way. 
At the planning stage of a clinical trial, investigators produce a 
research protocol that specifies the procedures and methods to be 
performed throughout the course of the trial. An appropriately 
constituted research ethics committee – be it an institutional research 
ethics board or a multicenter research ethics board – must approve this 
protocol for scientific thoroughness and ethical appropriateness. This 
may include, amongst other considerations, ensuring that the 
experimental design is sound, the number of research subjects will 
accurately represent an adequate statistical sample, there is a suitable 
informed consent process, if there is compensation being provided it 
is not unduly coercive, and that the proposed research is in accordance 
with current scientific practices and ethical/legal regulations. 
Clinical trials can be randomized (RCT) and nonrandomized. An 
RCT comprises two (or possibly more) experimental or treatment 
groups/arms in which trial subjects are randomly assigned into 
different groups to ensure internal validity. If there are two groups, one 
group receives the product being studied and the other group receives 
the standard therapy/product, or a placebo. Where possible, the highest 
standards for RCTs include blinding, where the trial subjects (single-
blind trial) or the trial subjects and investigators (double-blind trial) 
do not know which product is being tested. 
Non-randomized trials are sometimes conducted where 
randomization is impossible for ethical or pragmatic reasons. They 
face greater problems of bias, although these can sometimes be limited 
by careful design. When new therapies are tested in humans, especially 
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in the case of pharmaceutical therapies, RCTs generally comprise four 
progressive phases. 
The different types of clinical trials are as follows (with phase 
III trials usually being RCTs). 
Phase I. In this phase, products are tested on a small number of 
subjects to collect data on considerations such as toxicity and best 
method of administration. These subjects may be healthy volunteers 
or patients with specific conditions, depending on the type and nature 
of the product. Testing in this stage seeks to collect data on the 
pharmacokinetic action of products in humans, possible risks or side 
effects associated with products at different dosages, amongst other 
consideration. The number of subjects participating in this phase is 
usually under 100. If sufficient and appropriate data are collected in 
this preliminary phase, it is used to design phase II studies. 
Phase II. In this phase, products continue to be tested on a larger 
number of subjects to collect further data on pharmacological and 
pharmacokinetic activity, particularly in patients with the condition 
the product is proposed to treat. It is also at this stage that the new 
product is measured against the standard treatment or placebo for its 
comparative efficacy. The number of subjects participating in this 
phase is usually no more than several hundred. If sufficient and 
appropriate data are collected in this secondary phase, it is used to 
design phase III studies. 
Phase III. In this phase, the product is tested on an even larger 
number of subjects in a continued effort to evaluate the product’s 
safety and efficacy, especially in relation to standard treatments or 
placebos. At this stage, the product is generally dispensed as it would 
when it is to be marketed, and it is evaluated for its overall risk–benefit 
relationship and clinical labeling profile. The number of subjects 
participating in this phase is usually several hundred to several 
thousand.  
Phase IV. In this phase, which occurs only after the product has 
been approved and licensed for use, the product is evaluated for 
potential long-term side effects associated with the drug. This 
postmarketing surveillance phase could also include studies 
concerning how different dosages, schedules, or length of 
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administration of the product affect patients, or how different patient 
populations react to the product.  
In addition to the important exchange of information between 
study investigators, sponsors, and institutional/regulatory bodies, it is 
essential that the dissemination of results from clinical trials – positive, 
negative, and inconclusive results – occurs through peer-reviewed 
conferences and peer-reviewed journals; even if the results are 
unpublished, it is important that they are registered in a clinical trials 
registry. This ensures that clinicians and patients have access to the 
best information possible to make responsible decisions about what 
medical interventions are worthwhile undertaking. 
The ethical importance of clinical trials is sometimes 
underestimated. Yet the need to evaluate treatments for their safety 
and efficacy, so as to minimize harm to patients, reduce clinical 
uncertainty, and improve the efficiency of resource allocation, is great, 
as has been recognized since Archie Cochrane’s (1972) lectures on 
Effectiveness and Efficiency and the rise of the evidence-based 
medicine movement. Much more attention has been paid to the ethics 
of the conduct of clinical trials. The standard principles of research 
ethics apply to clinical trials, such that the avoidance of coercion and 
undue inducement, the properly informed consent of the patient, the 
proportionality of risk and benefit, and the scientific and clinical 
competence of the investigators all need to be assured. In recent years, 
attention has focused on the need to warrant randomization in clinical 
trials. The principal theory of the ethics of randomization is the 
“equipoise” theory. On this theory, clinicians discharge their 
responsibilities to do their best for their patients if, faced with genuine 
uncertainty as to which one of the available treatments is most 
effective (or safest) in treatment of a condition, they allocate the 
patient treatment by randomization, thereby giving the patient an equal 
chance of receiving the treatment which is actually most effective.  
At issue is the question of whether the uncertainty is genuine, 
and whether the patient understands this. Some patients can 
experience the “therapeutic misconception”, according to which they 
believe that the treatment they are receiving must be the treatment that 
is best for them, when this is actually not certain and the treatment is 
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in a broader or narrower sense ‘‘experimental’’. Current best practice 
is that uncertainty should be underwritten by the conduct of an 
appropriately rigorous systematic review of the existing clinical 
evidence before a trial is initiated; and a stronger claim is sometimes 
advanced, that where uncertainty exists a trial ought to be initiated. 
In practice, not all clinical trials exist to resolve clinical 
uncertainty, since many trials are run in order to establish the safety 
and licensure credentials of a new treatment, rather than to assess the 
merits of a new treatment in the light of the alternatives.  
Often there can be moral conflict in clinical trials between an 
investigator’s scientific duty and protective duty – with the 
predominant view being that, when in conflict, the protective duty 
must override scientific duty. Merritt (2005) has recently argued that, 
in such conflicts, we need not choose one duty over the other; instead, 
in hard cases, investigators should proceed by taking into 
consideration the interests that research subjects have in achieving 
their personal goals for participation in research. 
Evidence-based medicine (EBM) is to use in everyday medical 
practice (in the diagnosis, treatment and prevention), medical 
technology and medications effectiveness of that has been proven in 
pharmaco-epidemiological studies using mathematical estimates of 
the probability of success and risk. 
The main principle of EBM is every clinical decision should be 
based on scientific facts, reported a statistically representative at a 
large group of patients. 
The main method of EBM (Gold standard) is a randomized, 
controlled study in which patients are divided into groups randomly. 
There are following main pharmaco-epidemiological concepts 
to obtain evidence of the effectiveness of medical technologies: 
 the actual (final) clinical outcome;  
 mediated (indirect) the criterion of effectiveness; 
 the absolute risk;  
 the relative risk. 
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Questions for Self-checking 
1. What does the term “eugenics” mean? 
2. What powers do the ethical (bioethical) committees have? 
3. What qualities must the scientist-experimenter have? 
4. What is the main task of ethics committees? 
5. What work belongs to Francis Galton? 
6. Which international document contains ethical and legal 
principles for research on humans? 
7. What is Evidence-based medicine? 
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Topic 4. Modern biotechnology and biosafety software 
problems. Genetically modified organisms 
 
Main lecture questions:  
4.1 Biological hazard and levels of biosafety 
4.2 Basics of biotechnology 
4.3 Ethical issues of genetic engineering technologies 
4.4 Genetically modified organisms 
4.5 Genetic screening in pregnancy and abortion. Stem Cell 
research 
 
4.1 Biological hazard and levels of biosafety 
Biosecurity is a system of evidence-based measures to prevent 
or reduce to a safe level the potential adverse effects of genetic 
engineering and genetically engineered (transgenic) organisms on 
human health and the environment. 
The most important agreement regulating inter-state relations in 
this sphere is the Cartagena Protocol on Biosafety (2000), the 
Convention on Biological Diversity (1992). 
Justification of biosafety mechanisms as a system of measures 
“to ensure the secure creation, use and transboundary movement of 
living modified organisms resulting from biotechnology”, occupy a 
leading position in modern bioethics.  
The term “biological hazard” means “an infectious agent (or 
part of it), representing a potential danger to human health, animal 
and/or plant through direct effects: infection or indirect influence: 
through the destruction of the environment”. 
For different groups/categories of laboratory infections 
elaborated practical guidelines that describe the appropriate equipment 
for the safe storage of biological material, the necessary equipment 
and activities to be performed by laboratory personnel. These 
guidelines are called biosafety levels (BSL). There are four levels, 
each of which consists of the primary and secondary barriers and 
microbiological procedures features.  
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The first level corresponds to the minimum risk of infection; 
work with microorganisms of pathogenicity class 4 requires 
compliance with the maximum precautions. 
Biosafety Level 1. Rules of work, in accordance with safety 
equipment and laboratory premises, are suitable for use with known 
strains of microorganisms with which human cases of the disease are 
not registered. The laboratory does not have to be isolated from the 
premises of the building. Work may be performed on a conventional 
lab bench to standard microbiological procedures. Special protective 
equipment required and/or is not used. Laboratory personnel passes 
the usual safety training and is under the supervision of the chief 
laboratory with experience in a standard microbiology laboratory. 
Biological safety cabinet when working with these strains of micro-
organisms are not required. 
Biosafety Level 2. Rules of work, in accordance with safety 
equipment and laboratory premises, are suitable for a wide range of 
known microorganisms belonging to the moderate-risk group, causing 
human disease of moderate severity. 
The main differences from the Biosafety Level 1 are: 
a) laboratory personnel receive specific training in handling 
pathogenic microorganisms under the guidance of experienced 
professionals; 
b) the access to the laboratory is limited during the operation; 
c) careful handling of sharps is recommended; 
d) special precautions for handling are required, in which 
aerosols and/or spray can be formed. We recommend the use of 
physical barriers to protect. It is highly recommended to work in a 
biological safety cabinet class I and class II. 
Biosafety Level 3. Rules of work are in accordance with safety 
equipment and laboratory space suitable for working with local and 
exotic microorganisms transmitted by airborne droplets and cause 
severe illness or even death. Particular attention should be paid to the 
protection of personnel (primary and secondary barriers) as well as the 
protection of society and the environment. Essential requirement: 
works in the biological safety cabinet class I and class II. 
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Biosafety Level 4. Rules of work are in accordance with safety 
equipment and laboratory space fit for work with dangerous and exotic 
strains of microorganisms that represent a high risk to human health 
and life. Diseases are transmitted by airborne droplets or unknown 
ways and do not respond to treatment; drugs and vaccines are not 
available. Laboratory personnel undergo special training and a 
thorough safety work with dangerous microorganisms and is under the 
supervision of a specialist who has experience of such work. Entrance 
to the laboratory is strictly limited. The laboratory is located in a 
separate building or in a completely isolated part of the building. 
Special rules of work in the laboratory. The presence of a biological 
safety cabinet class III is strictly necessary. 
Practical advice on biosafety. 
1. The laboratory should always take precautions when dealing 
with blood and body fluids, as well as the use/storage of sharp objects, 
to conduct treatment arms (universal precautions). 
2. Do not eat, drink or smoke in the laboratory. Food cannot be 
stored in cold rooms used for the storage of clinical material. 
3. Do not spend mouth pipetting – use the appropriate 
mechanical devices. 
4. Disinfect countertops daily, if necessary (in case of accidental 
contact with the biological material). 
5. Use latex gloves of a suitable size. 
6. It is necessary to use face shields or masks and eye protection 
in situations where there is a high probability of accidental exposure 
to blood and body fluids. 
 
Table 4.1 – Characteristics of biological safety levels 
 
Level 
Microorganisms 
description 
Examples of 
microorganisms 
Safety Rules 
Necessary equipment 
(primary barrier) 
Optional equipment 
(secondary barrier) 
1 2 3 4 5 6 
1 Do not cause the 
development of infections 
in healthy adults 
 
Bacillus subtilis, 
Naegleria gruberi, 
Infectious canine 
Standard rules of 
work in the lab  
Does not require Sink 
2 Associated with human 
diseases. Transmission 
risk: damage to the skin, 
ingestion, mucous 
membranes 
Measles virus, 
Salmonellae, 
Toxoplasma spp 
Level 1 and: 
• access limitation; 
• signs of biological 
hazards; 
• strict precautions; 
• waste management 
and medical 
supervision.  
Biological safety cabinet 
class 1 and 2. Personal 
protection: gown, gloves, 
mask (if necessary)  
Level 1 and the presence 
of the autoclave 
Level 1 and the presence 
of the autoclave 
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Continuation of Table 4.1 
1 2 3 4 5 6 
3 Dangerous bacteria, 
usually transmitted by 
aerogenic route, can 
lead to diseases with a 
fatal outcome 
 
M.Tuberculosis, 
St. louis 
encephalitis 
virus, Coxiella 
Burnetti 
Level 2 and: 
• access limitation; 
• decontamination 
of waste and 
laboratory clothing; 
• medical 
monitoring 
employees 
 
Biological safety 
cabinet class 1 and 2, 
and physical barriers 
for all open 
manipulations. 
Personal protection: 
gown, gloves, mask (if 
necessary) 
 
Level 2 and: 
• separation of the 
laboratory from the 
common areas; 
• system self-closing 
double doors; 
• lack of the 
recirculation exhaust air; 
• creation of a low-
pressure laboratory 
4 The microorganisms 
that cause life-
threatening or 
intractable infection 
treatment, transmitted 
mainly by aerogenic 
route (e. g., viruses of 
hemorrhagic fevers) 
Ebolla Zaire, 
Sin Nombre 
virus, Rift 
Valley Fever 
Level 3 and: 
• changing of 
clothes before 
entering the lab; 
• shower after 
coming out of the 
lab; 
• full 
decontamination 
clothes after leaving 
the lab 
 
Biological safety 
cabinet class 3 or 
biological safety 
cabinet class 1 or 2 in 
combination with 
special coveralls for 
staff (completely 
closed body, air flow, 
high blood pressure) 
 
Level 3 and: 
• the location of the lab 
in a separate building (or 
strictly isolated); 
• the separate 
feeder/vacuum release 
system of 
decontamination; 
• adherence to additional 
requirements for 
microbiological and 
biomedical laboratories 
 
6
4
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4.2 Basics of biotechnology 
Biotechnology involves the use of living organisms in industrial 
processes – particularly in agriculture, food processing, and medicine. 
Biotechnology has been around since the dawn of time, ever since 
humans began manipulating the natural environment to improve their 
food supply, housing, and health. Biotechnology is not limited to 
humankind. Beavers cut up trees to build homes. Elephants 
deliberately drink fermented fruit to get an alcohol buzz. People have 
been making wine, beer, cheese, and bread for centuries. 
The reason of biotechnology as modern is because of recent 
advances in molecular biology and genetic engineering. Huge strides 
have been made in our understanding of microorganisms, plants, 
livestock, as well as the human body and the natural environment. This 
has caused an explosion in the number and variety of biotechnology 
products. 
“Red” biotechnology is the production of pharmaceuticals for 
the diagnosis and treatment of various human diseases and correction 
of the genetic code. 
“White” biotechnology is the production of enzymes and 
biomaterials for the food industry. 
“Green” biotechnology is the development and introduction to 
the culture of genetically modified plants, the creation of new animal 
breeds.  
Genetically modified plants have genes inserted to protect them 
from insects, thus increasing the crop yield while decreasing the 
amount of insecticides used. Medicines are becoming more specific 
and compatible with our physiology. For example, insulin for diabetics 
is now genuine human insulin, although produced by genetically 
modified bacteria. Almost everyone has been affected by the recent 
advances in genetics and biochemistry.  
Each organism, even the lowly gene creatures, is based on DNA. 
DNA and RNA have unique structures that ensure their survival and 
existence in all facets of life. Each structure has a backbone of 
alternating phosphate molecules with sugar residues. In DNA, the 
sugar, deoxyribose, is missing a hydroxyl group on the 2′carbon. The 
bases, which attach at the 1′carbon, form pairs so that adenine joins 
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with thymine and guanine joins with cytosine. These pairs are held 
together with hydrogen bonds that induce the two backbones to twist 
into a double-stranded helix. In RNA, the sugar, ribose, has one extra 
hydroxyl group, and the base thymine is replaced with uracil. 
Many different organisms are used in biotechnology research, 
and they have a particular trait that is useful to study new genes.  
Gramnegative bacteria (fig. 4.1) have three structural layers 
surrounding the cytoplasm. The outer membrane and cytoplasmic 
membrane are lipid bilayers, and the cell wall is made of 
peptidoglycan. Unlike eukaryotes, no membrane surrounds the 
chromosome, leaving the DNA readily accessible to the cytoplasm. 
 
 
Figure 4.1 – Subcellular Structure of Escherichia coli 
 
Bacteria are genetic clones that are easily grown and stored for 
long periods of time. Two key traits are their simple genomes and 
availability of plasmids to alter their genetic makeup. Although useful, 
bacteria are prokaryotes and differ greatly from humans. Therefore, 
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eukaryotic model organisms are also used for research. Yeasts are 
single-celled eukaryotes that have similar traits to human cells, such 
as multiple chromosomes, a nucleus, and various organelles. In 
addition, yeasts also have plasmids in which extra genes can be added 
to study in a model organism. Finally, the chapter outlines the key 
traits of multicellular organisms from barely visible roundworms such 
as C. elegans to mice, cultured human, animal, and insect cells, and 
the model plant organism, Arabidopsis. 
Besides real organisms, research in biotechnology relies on gene 
creatures such as viruses, transposons, and plasmids. These genetic 
vehicles are critical to manipulating the genome of the model 
organisms. In fact, viruses may be the key to accomplishing gene 
therapy in humans also. 
Viruses are used as vehicles to inject foreign DNA into a host 
cell. Transposons are also used to deliver new genes into the host 
DNA. Plasmids are used for the same purpose, but do not work in 
higher organisms and, therefore, are restricted to cultured cells, yeast, 
and bacteria. The use of gene creatures and model organisms is key to 
biotechnology research. 
 
4.3 Ethical issues of genetic engineering technologies 
Genetic engineering means that we alter an organism 
permanently so that the changes will be stably inherited.  
Introducing genes technique into bacteria has been developed 
after Frederick Griffith discovered the phenomenon of bacterial 
transformation. 
Transfer desired genes within the vector may be accomplished 
using several methods, such as: 
 microinjection; 
 electroporation; 
 transport DNA liposome composition; 
 microparticle bombardment (ballistic transformation 
method); 
 use of the bacterium Agrobacterium tumefaciens. 
For multicellular organisms this implies deliberate alteration of 
the DNA in the germline cells. In contrast, gene therapy (occasionally 
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called genetic surgery) is less permanent. The patient is cured, more 
or less, by altering the genes in only part of the body.  
For example, cystic fibrosis patients might be partially cured by 
introducing the wild-type gene into the lungs. However, these changes 
are not inherited, and the alleles in the germline cells remain defective. 
The main steps involved in replacement gene therapy are as 
follows: 
a) identification and characterization of gene; 
b) cloning of gene; 
c) choice of vector; 
d) method of delivery; 
e) expression of gene. 
Severe combined immunodeficiency (SCID) occurs when both 
the B cells and T cells of the immune system are defective and results 
in an almost totally defective immune response. Children with SCID 
have to be shielded from all contact with other people and are kept 
inside special sterile plastic bubble chambers. Without immune 
protection any disease, even a cold, could prove fatal. Several genetic 
defects are known that cause SCID. About 25 % are due to mutations 
in the Ada gene that encodes the enzyme adenosine deaminase. This 
is needed for the metabolism of purine bases, and its absence prevents 
development of lymphocytes (white blood cells including both the B 
cells and T cells). 
The first successful instance of human gene therapy used a 
retroviral vector to provide a functional copy of the Ada gene to a child 
with SCID. The cells affected by SCID are the lymphocytes that 
circulate in the blood, where they carry out immune surveillance. They 
are produced by division of bone marrow cells (Fig. 4.2). Gene therapy 
involves removing bone marrow cells from the patient and 
maintaining them in cell culture outside the body.  
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Figure 4.2 – Ex Vivo Retroviral Gene Therapy  
for Ada Deficiency 
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About 75 % of gene therapy trials have used viral vectors. A 
variety of alternative approaches have also been investigated, though 
few have been effective or widely used so far. These include: 
a) use of naked nucleic acid (DNA or less often RNA). Many 
animal cells can be transformed directly with purified DNA. The 
therapeutic gene may be inserted into a plasmid and the plasmid DNA 
used directly. Some 10 % to 20 % of gene therapy trials have used 
unprotected nucleic acid; 
b) particle bombardment. DNA is fired through the cell walls 
and membranes on metal particles. This method was originally 
developed to get DNA into plants. However, it has also been used to 
make transgenic animals and is occasionally used for humans; 
c) receptor-mediated uptake. DNA is attached to a protein that 
is recognized by a cell surface receptor. When the protein enters the 
cell, the DNA is taken in with it; 
d) polymer-complexed DNA. Binding to a positively charged 
polymer, such as polyethyleneimine, protects the negatively charged 
DNA. Such complexes are often taken up by cells in culture and may 
in principle be used for ex vivogene therapy; 
e) encapsulated cells. Whole cells engineered to express and 
secrete a needed protein may be encapsulated in a porous polymeric 
coat and injected locally. Foreign cells excreting nerve growth factor 
have been injected into the brains of aging rats. The rats showed some 
improvement in cognitive ability, suggesting that this approach may 
be of value in treating conditions such as Alzheimer’s disease; 
f) liposomes are spherical vesicles composed of phospholipid. 
They have been used in around 10 % of gene therapy trials (see later 
discussion). 
 
4.4 Genetically modified organisms 
Transgenic Crop plants. There has been considerable 
controversy over the use of transgenic plants in agriculture.  
Although the term genetically modified organism (GMO) is 
often used, we should remember that all domesticated plants and 
animals have been genetically modified by more traditional methods 
and consequently differ greatly from their wild ancestors. There are 
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three main issues to consider for transgenic crops. First is whether the 
food product is safe for human consumption. Second is the question 
of containment. Third is the question of hazard to the environment. 
Containment of transgenic plants is unrealistic on an agricultural 
scale. In practice, seeds from different batches of corn are impossible 
to keep wholly separate, and mixing of GMO with natural corn has 
occurred. DNA of transgenic origin has been detected in wild plants. 
For example, wild maize (corn) in Mexico examined in 2001 
contained transgenic DNA, even though planting transgenic corn 
plants was stopped in 1998. Worrisome possibilities include genes for 
herbicide resistance moving from crop plants to weeds. This would 
make weed control more difficult. Similarly, insecticide toxins 
expressed in pollen grains might harm bees, impairing the pollination 
of crops that depend on the bees.  
Perspectives on GMO food vary greatly (Table 4.2) but seem 
rather predictable, based on known vested interests. Those who grow, 
export, and profit from GMO crops claim that they are safe and that 
the controversy is largely an emotional overreaction. Originally, the 
corporations and farmers were overall pro-GMO. However, the 
terminator controversy caused a rift between these two groups. 
Environmental and consumer groups tend to oppose GMO, as with any 
new technology. 
 
Table 4.2 – Percentage of GM Crops by Region (2004 Data) 
Country % 
USA 59 
Canada 6 
Argentina 20 
Brazil 6 
China 5 
Others 4 
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Loss of Biodiversity. Genetic engineering followed by cloning 
to distribute many identical animals or plants is sometimes seen as a 
threat to the diversity of nature. However, humans have been replacing 
diverse natural habitats with artificial monoculture for millennia. Most 
natural habitats in the advanced nations have already been replaced 
with some form of artificial environment based on mass production or 
repetition. The real threat to biodiversity is surely the need to convert 
ever more of our planet into production zones to feed the ever-
increasing human population. The cloning and transgenic alteration of 
domestic animals makes little difference to the overall situation. 
Conversely, the renewed interest in genetics has led to a growing 
awareness that there are many wild plants and animals with interesting 
or useful genetic properties that could be used for a variety of as-yet-
unknown purposes. This has led in turn to a realization that we should 
avoid destroying natural ecosystems because they may harbor 
tomorrow’s drugs against cancer, malaria, or obesity. 
One divisive aspect of the GMO controversy was the 
development of “terminator” technology. Crop plants were engineered 
so that their seeds would be sterile. The pretense was that this would 
prevent escape of GMO plants into the wild. The underlying motive 
was mere greed. Farmers would be forced to buy a new supply of seeds 
each year instead of planting seeds saved from the previous year’s 
harvest. This would both increase the profits of the seed corporation 
and make farmers dependent on their seed suppliers. The attempted 
use of terminator technology to blackmail farmers caused a great deal 
of ill feeling. 
The terminator scheme involves three transgenes: 
1. A gene for a toxin that is lethal only in developing seeds. The 
toxin gene is otherwise inactive due to a DNA spacer flanked by loxP 
sites inserted between the promoter and the coding sequence. 
2. A gene for Cre recombinase, which recognizes the loxP sites 
and recombines them so deleting the spacer sequence. This allows 
expression of the toxin gene. 
3. A gene encoding a variant of the TetR repressor that prevents 
expression of the Cre recombinase gene.  
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Before sale, the seeds are soaked in a solution of tetracycline that 
binds to and inactivates the repressor. This allows the Cre recombinase 
to become active and remove the spacer sequence. The toxin gene is 
now expressed. Because the toxin does not harm the growing plant, 
except for the developing seeds, the crop grows normally except that 
the seeds are sterile. 
Transgenic Animals and Animal Cloning. Humans have 
meddled with nature since time immemorial. Historically humans 
have altered animals and plants by deliberate selective breeding and 
hybridization. In addition, human activity has led to unconscious 
genetic modification of many organisms. For example, we have 
undoubtedly selected alterations in the mice that infest our fields and 
grain storage facilities and the insects that rely on human crops. The 
novelty of genetic engineering is not in what we are doing, but in how 
we do it. Today we generate transgenic organisms by direct 
manipulation of their genetic material. 
Even if you devote a whole field to growing a crop plant that is 
natural, you are eliminating the natural inhabitants of that patch of 
land. Moreover, you will select for life forms – both weeds and insect 
pests – that adapt to croplands. The European corn borer is a huge 
threat to the corn crop, but if we did not grow so much corn, these 
insects would be rare. Whether we want to or not, whether we are 
aware of it or not, we are imposing genetic selection on many other 
organisms, whatever we do. 
Genetic manipulations could create future organisms that are 
truly bizarre by today’s standards. By manipulating the homeobox 
genes, which control body plans and segmentation, maybe a 
“chickapede” – a chicken with multiple legs and body segments –
could be created. Perhaps more grotesque would be to develop feed 
animals lacking most of the brain. This would avoid the suffering of 
domestic animals that are kept for slaughter. The controversy 
surrounding such future creations is yet to arise. 
 
  
74 
4.5 Genetic screening in pregnancy and abortion. Stem Cell 
research 
Genetic screening of newborn babies has been practiced for 
some time. Such information is used to allow early treatment of 
newborn infants, the classic case being phenylketonuria (PKU). 
People with PKU lack the enzyme that converts phenylalanine to 
tyrosine, and excessive amounts of phenylalanine causes permanent 
brain damage.  
Newborn screening allows infants with PKU to be given a diet 
low in phenylalanine, greatly reducing the damage. More recently it 
has become possible to screen developing fetuses for a variety of 
genetic defects long before birth. Analytical techniques are constantly 
advancing and an ever-increasing list of inherited defects can be 
monitored, at ever earlier stages of development. 
However, prenatal genetic screening could also be used to 
decide whether to abort a fetus destined to suffer from an inherited 
defect. As understanding of the human genome increases, it will 
become possible to deduce such things as the probable future height, 
eye color, IQ, and beauty of the developing fetus. Most parents would 
like to have smart, healthy, and attractive children, and the temptation 
to have abortions based on these characteristics will soon become a 
reality. 
The abortion issue is of course a peculiarly American obsession. 
Most European nations legalized abortion in the 1950s, and few 
Europeans take seriously the moralistic pronouncements on this issue 
that come from the other side of the Atlantic. The central question of 
the abortion issue is “When does human life start?” From a biological 
perspective, life does not start at one particular point but is a 
continuum. Sperm cells are alive, and so are the eggs they fertilize. 
Fusion of egg and sperm to create a zygote forms a new living 
individual with a unique genetic constitution. Rather than the 
beginning of life, the issue is perhaps really about consciousness. 
When do we actually become a conscious being? This is impossible to 
answer because no one yet understands consciousness, let alone has 
the ability to measure it. 
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Because society has arbitrarily decided that abortion is legal 
until the end of the first trimester, who should decide if an abortion is 
to be performed? From a genetic viewpoint, both father and mother 
have an equal share in the new individual – except for the 
mitochondrial DNA that is maternal in origin. From the viewpoint of 
biological resources, the mother has more invested and has 
traditionally been allowed to make the decision.  
Thus, the father often has fewer rights over the children. 
Although this outlook was not deliberately based on evolutionary 
considerations, it does in fact coincide with Darwinian logic. 
Stem Cell research. Another issue that has become entangled 
with the abortion controversy is stem cell research. Stem cells are the 
precursors to the differentiated cells that make up the body. Different 
types of stem cells correspond to different types of tissues. Embryonic 
stem cells are found in the developing embryo and retain the ability to 
develop into any body tissue. Embryonic stemcells can be maintained 
in culture and may be used to create transgenic animals by insertion of 
DNA. 
It is hoped that engineered stem cells will eventually be used to 
regenerate damaged tissues or organs. One controversy concerns the 
source of the embryonic stem cells. In particular, should they be taken 
from discarded fetuses? One side claims that stem cell research will 
encourage abortions just to provide material. The other side claims that 
stopping research will deny patients medical improvements such as 
organ replacements. A related issue is the use of stem cells from 
leftover embryos in fertility clinics. Because few stem cells are needed 
for research, and vast numbers of aborted fetuses already exist, 
increased numbers of abortions seems unlikely. 
In addition, no one has yet grown an actual human organ from a 
stem cell. Thus this controversy is based on possibilities, not realities. 
One suspects that if technology advances far enough to grow organs 
in culture, it will also allow the use of stem cells from the patient’s 
own body and embryonic tissue will no longer be required. 
Stem cell research merges into other areas of biotechnology. If 
scientists are not allowed to use existing aborted tissue, can they create 
their own embryos in vitro? How far should such embryos be allowed 
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to develop? Should brain tissue be used, since that is where people 
believe our consciousness lies? 
Forensics and Crime. Obviously any technology that is used to 
combat crime can be abused. Forensic Molecular Biology, the use of 
DNA for identification in both criminal investigations and civil cases 
(mostly paternity suits) is now widely accepted (Fig. 4.3).  
 
 
Figure 4.3 – Acceptance of DNA Evidence in Today’s Culture 
 
Early technical problems have been ironed out, and the 
probabilities are now so overwhelming that, when properly done, 
DNA analysis can give a reliable and essentially unique identification. 
In fact, one major result of using DNA evidence has been the release 
of significant numbers of suspects who were wrongly convicted based 
on less reliable means of identification. 
The remaining ethical issues concern such matters as setting up 
national or international databases of criminal DNA records. Who will 
be included? Who will have access? At the moment, DNA sequences 
used in identification are located in regions of noncoding DNA. 
However, it may eventually be possible to deduce a person’s physical 
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appearance and mental characteristics from DNA. If this is feasible, 
will DNA left at a crime scene be further analyzed to provide this 
information about possible suspects? 
New advances in both knowledge and technical capability bring 
new ethical and regulatory problems. Closer inspection suggests that 
many new ethical issues are merely old issues in a new guise. Other 
issues do not involve ethics so much as familiarity. Nonetheless, some 
aspects of genetic engineering, such as transgenics and human cloning, 
do pose questions that are at least partly new. 
 
Questions for Self-checking 
1. Should people be allowed to clone their pets? 
2. Is prescientific selective breeding accepable? 
3. Is applying Mendelian genetics acceptable? 
4. Is genetic engineering admissible as long as no foreign DNA 
is introduced from another species? 
5. Would it be good enough to develop a chicken with, say, 10 
legs for food? 
6. Are European views on abortion (and related issues) more 
advanced or more degenerate than American attitudes? 
7. Should prenatal genetic screening be allowed for inherited 
diseases? 
8. Should defective fetuses be terminated by abortion? Who 
should make the decision whether a defective fetus lives or dies? 
9. Should we enforce paternity tests to make sure that the true 
genetic parents of a child are notified of any decisions about the child’s 
welfare? 
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Topic 5. Infectious diseases and problems of biosafety. 
Bioterrorism as a threat to biological security 
 
Main lecture questions:  
5.1 Infectious diseases: ethical and biosafety issues 
5.2 History of biological weapons 
5.3 Bioterrorism and germ warfare 
5.4 Long-term biological problems 
 
5.1 Infectious diseases: ethical and biosafety issues 
Infections are important because they are major causes of 
disease, death, and disability. Paradoxically, most are curable and 
many are preventable. They are unique in that they can be knowingly 
or unintentionally transmitted from person to person. They cause 
serious epidemics and devastating pandemics. Finally, despite 
remarkable technical progress that has radically diminished the 
incidence of childhood infections in developed countries and entirely 
eliminated smallpox, new infectious diseases such as Ebola virus 
infections, severe acute respiratory distress syndrome (SARS) and 
Avian influenza continue to emerge, evolve, and kill significant 
numbers of people and frighten and threaten many more. Infectious 
diseases entail some unique ethical features that are often encountered 
by public health officials.  
The fact that nearly all infectious diseases are caused by 
microorganisms and that many are relatively easily transmissible, 
diagnosable, treatable, curable, and preventable leads to the 
characteristic ethical problems that arise in the context of this class of 
diseases. Patients often bring these problems directly to physicians 
when they present for diagnosis, treatment, or preventive care.  
Ethical problems arise from conflicts between values, 
principles, and interests. Infectious diseases ethics examines how 
features of infection shape these problems, especially the tension 
between honoring patients’ preferences and preventing harm to others. 
The transmissibility of an infection, such as tuberculosis or 
gonorrhea, places a physician’s duty of confidentiality to the patient 
in conflict with a duty to society and an obligation to obey the law. 
79 
This may entail reporting the infected patient to public health 
authorities so that they can investigate an epidemic, alert contacts, and 
arrange diagnostic testing and treatment. Such mandatory reporting 
may be inconsistent with the patient’s expectation of confidentiality. 
The doctor can remind the patient that he, himself, can alert his 
contact(s) to their exposure and reduce the shock of a public health 
visit. 
Because diagnostic tests for infection in symptomatic and even 
asymptomatic individuals have value to others, the usual calculus of 
benefit and risk to the patient may be expanded to include those 
benefits. The standard practice of voluntary informed consent may be 
modified to accommodate strong recommendations, presumed 
consent, or required testing. It was common practice in the USA, for 
instance, to test all hospitalized patients for syphilis without their 
informed consent when this infection was more prevalent. Screening 
of refugees for the human immunodeficiency virus (HIV) and hepatitis 
B is currently carried out. 
The generally safe, effective, brief, and relatively inexpensive 
treatment and cure of infectious diseases make it unusual for patients 
to refuse treatment and more difficult for doctors to understand and 
accept such refusals. If the patient’s infection is likely to be transmitted 
to others, as tuberculosis would be, his/her refusal is even more 
problematic. As so many infectious diseases can be prevented, 
physicians have opportunities and perhaps a duty to recommend 
measures to prevent them. 
Sometimes this could help patients to avoid a serious, difficult 
to treat infectious disease such as tetanus. In many cases, like measles 
or hepatitis B, disease prevention for the patient, such as 
immunization, also provides protection for the community. 
Therefore, the physician may not always be able to offer the 
patient the usual option to refuse an intervention since some 
immunizations, such as polio and yellow fever, may be required for 
school entry or travel to another country. 
Because some infectious diseases, such as meningitis, occur 
suddenly, advance rapidly, and impair cognitive function, there may 
be only a brief time during which patients can participate in medical 
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decision making. Although most patients acquiesce quickly to 
diagnostic tests and antibiotic treatment, refusals of either can be very 
disconcerting. It is important to investigate the patient’s reasons for 
refusing a diagnostic test and correct any misunderstandings that 
contribute to the refusal. The person-to-person transmissibility of 
infectious disease in the context of a medical encounter makes this 
category of diseases unique and raises special ethical issues. The 
problem was first recognized by transmission of group A streptococci 
on doctors’ hands to obstetric patients, who developed puerperal fever. 
Recent concerns have focused on the possible, but rare, transmission 
of hepatitis B and HIV between patient and doctor or dentist. 
Does the doctor have an obligation to accept some level of 
personal risk to care for a patient with a communicable disease? Does 
a doctor with a transmissible infection have a duty to avoid or 
anticipate the risk of transmission and, if the risk is not eliminated, to 
disclose it to patients? 
The duty to do good for the patient and provide competent 
medical care is not obviated by an exaggerated fear of personal risk. 
Doctors with no likely exposure to a patient’s blood or bodily fluids 
have no basis for avoiding their duty to care for their patient with an 
infection transmitted via these fluids. Clinicians who risk such 
accidental exposure in the course of surgery or procedures have an 
understandable concern about personal risk. An appropriate way to 
address it is to use prevention when possible, such as personal 
immunization against hepatitis B, universal precautions, safe needle 
use, and masks and gowns when appropriate to minimize transmission 
of blood- and fluid-borne pathogens. 
It is not appropriate to test patients for infections like HIV 
surreptitiously and/or decline to provide medically necessary 
treatment to them because of a known or suspected infection. If 
medical treatment is withheld for that reason and the doctor offers an 
alternative but untrue explanation for the refusal, it is even more 
ethically inappropriate. 
If a doctor has likely been exposed to a transmissible pathogen, 
he/she has two reasons to determine if an infection has occurred. The 
first is their personal health, since many infectious diseases such as 
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HIV, hepatitis B, and syphilis can be averted or effectively treated if 
suspected or diagnosed at a very early stage.  
The second is to prevent inadvertent transmission to a patient. If 
a doctor discovers that he or she has an infectious disease transmissible 
in the context of their practice, the doctor should comply with the 
policy that governs such situations in that institution. In the absence of 
a policy, doctors should seek advice from an infectious disease 
specialist, preferably the hospital’s infection control officer and also 
determine whether any overriding public health policies apply. 
 
5.2 History of biological weapons 
Early attempts. The early use of biological weapons included 
the contamination of water with animal carcasses and filth. Another 
ancient tactic was to allow an enemy to take sanctuary in an area 
endemic for an infectious agent in anticipation that the enemy force 
would become infected, for example, allowing unimpeded access of 
opposing forces to areas where transmission of malaria was highly 
likely. One of the most notorious early biological warfare methods was 
the hurling of cadavers over the walls of besieged cities, primarily as 
a terror tactic. De Mussis provided a dramatic record of the use of 
plague victims in biological warfare. The plague, later known as the 
Black Death, was spreading from the Far East and reached the Crimea 
in 1346. 
Smallpox was particularly devastating to Native Americans. The 
unintentional yet catastrophic introduction of smallpox to the Aztec 
empire during the Narváez expedition of 1510, and its subsequent 
spread to Peru in advance of Pizarro’s invasion of the Inca empire, 
played a major role in the conquest of both empires. 
At the conclusion of the French and Indian War in 1763, the 
Native Americans conducted a series of attacks against British forts 
along the western frontier in what is known as Pontiac’s Rebellion. An 
outbreak of smallpox at Fort Pitt presented an opportunity to take 
advantage of the Native Americans’ unique susceptibility to this 
disease. 
The early era of modern microbiology and the world wars. The 
birth of scientific bacteriology during the 19th century provided the 
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scientific and technical basis for modern biological weapons 
programs. The Hague Conventions of 1899 and 1904 outlawed the use 
of “poison or poisoned arms”, although the possible use of 
bacteriological weapons was not specifically identified or addressed. 
Germany started the first known scientific, state-sponsored biological 
weapons program during World War I.  
Sixteen espionage agents reportedly undertook a covert 
biological campaign in the United States before the United States 
entered the war. The Allies had purchased US draft animals for 
military use, and German operatives infected these animals with 
glanders and anthrax while they were awaiting shipment overseas. 
The Germans also conducted similar operations in Romania, 
Russia, Norway, Mesopotamia, and Argentina, with varying levels of 
success. Attempts were also made to cripple grain production in Spain 
with wheat fungus, but without success. 
Eleven Chinese cities were allegedly attacked during “field 
trials” using infectious agents including Yersinia pestis, Vibrio 
cholerae, and Shigella. These attacks may have backfired because up 
to 10 000 Japanese soldiers reportedly contracted cholera after a 
biological attack on Changde in 1941. As a result of the Japanese 
biowarfare program, 580 000 people are estimated to have died in 
China.  
Vaccine research and development was conducted at both Tokyo 
University and Unit 731. By the end of the war, the Japanese 
biowarfare program claimed to have effective vaccines for anthrax, 
cholera, dysentery, typhoid, and typhus.  
Polish physicians used a vaccine and a serologic test during 
World War II in a brilliant example of “biological defense”. Knowing 
that inoculation with killed Proteus OX-19 would cause a false-
positive Weil–Felix typhus test, Polish physicians inoculated the local 
population with a preparation of formalin-killed Proteus OX-19 to 
create a serologic pseudoepidemic of typhus. Using serologic 
surveillance, the German army avoided areas that appeared to contain 
epidemic typhus; consequently, residents of these areas were spared 
by deportation to concentration camps.  
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Several reported but unconfirmed allegations indicate that 
Polish resistance fighters conducted biological warfare against Nazi 
occupation forces, including using letters contaminated with Bacillus 
anthracis to cause cases of cutaneous anthrax among Gestapo officials 
and using typhus against German soldiers.  
The perceived threat of biological warfare before World War II 
prompted Great Britain to stockpile vaccines and antisera, establish an 
emergency public health laboratory system, and develop offensive 
biological weapons. “Cattle cakes” consisting of cattle feed 
contaminated with B anthracis spores were designed to be dropped 
from aircraft into Axis-occupied Europe to cause epizootic anthrax 
among livestock, which would in turn induce famine. 
The US program. The US military recognized biological 
warfare as a potential threat after World War I. Major Leon Fox of the 
Army Medical Corps wrote an extensive report concluding that 
improvements in health and sanitation made biological weapons 
unfeasible and ineffective. In the fall of 1941, before the US entry into 
World War II, opinions differed about the threat of biological warfare. 
In 1951, the first biological weapons, anticrop bombs, were produced. 
The first antipersonnel munitions were produced in 1954, using 
Brucella suis. The United States weaponized seven antipersonnel 
agents and stockpiled three anticrop agents (see  
Table 5.1) in 16 years. 
 
Table 5.1 – Biological agents produced by the US military (destroyed 
1971–1973) 
Lethal Agent Incapacitating Agent Anticrop Agent 
Bacillus anthracis 
Francisella tularensis 
Botulinum toxin  
 
Brucella suis 
Coxiella burnetii 
Venezuelan equine 
encephalitis virus  
Staphylococcal 
enterotoxin B 
Rice blast 
Rye stem rust 
Wheat stem rust 
However, the US military has never used biological weapons. 
The Central Intelligence Agency developed weapons using toxins 
including cobra venom and saxitoxin for covert operations; all records 
84 
regarding their development and deployment were destroyed in 1971. 
Most tests used simulants thought to be nonpathogenic, including 
Bacillus globigii, Serratia marcescens, and particulates of zinc 
cadmium sulfide. 
Open-air releases of human pathogens (Coxiella burnetii, 
Francisella [Pasturella] tularensis) were remote Pacific Ocean sites 
to study viability and infectivity using animal challenge models. 
Controversial studies included environmental tests to determine 
whether African Americans were more susceptible to Aspergillus 
fumigatus, as had been observed with Coccidioides immitis. These 
studies included the 1951 exposure of uninformed workers at Norfolk 
Supply Center in Norfolk, Virginia, to crates contaminated with 
Aspergillus spores.  
The first large-scale aerosol vulnerability test conducted in San 
Francisco Bay in September 1950 using B globigii and S marcescens 
demonstrated the public health issues of such testing. An outbreak of 
11 cases of nosocomial S marcescens (Chromobacterium 
prodigiosum) urinary tract infection occurred at the nearby Stanford 
University Hospital; one case was complicated by fatal endocarditis. 
Risk factors included urinary tract instrumentation and antibiotic 
exposures. 
 
5.3 Bioterrorism and germ warfare 
Objectively, the likelihood of surviving a biological attack is 
much better than surviving a nuclear strike. Despite this, those who 
are unfamiliar with microbiology tend to find biological warfare very 
frightening and often regard it as more immoral than chemical or 
nuclear warfare. This disproportionate response to germ warfare can 
be seen in the hysterical response of the United States to the anthrax 
attacks of 2001–2002 that followed the terrorist destruction of the 
World Trade Center. The actual number of casualties was low, yet the 
associated fear was widespread and became a hot media topic. Perhaps 
one major reason for the fear is lack of visibility. Guns and bombs are 
highly visible. Infectious microbial agents are invisible to the naked 
eye. The fear of invisible dangers can become quite obsessive. 
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Whether or not research on germ warfare should be done is hotly 
debated. Knowing how to protect against an infectious disease 
inevitably provides information that would help in using the disease 
against an enemy. This conundrum is true in other areas. For example, 
the technology to build a nuclear power station is closely related to 
that needed to develop nuclear weapons. The same body of knowledge 
can often be applied to both positive and negative objectives. 
Another issue is that of the Third World versus the industrial 
nations. Germ warfare has been described as the “poor man’s nuclear 
weapon”. Nations too poor to develop costly high-tech weapons could 
throw together crude biological weapons relatively easily and cheaply. 
Germ warfare thus represents a possible means by which Third World 
nations could protect themselves against the rich nations. This aspect 
is compounded by the fact that soldiers from rich countries have higher 
life expectancies and a better quality of living than do the poor 
inhabitants of the Third World. Thus a poor dictatorship might be 
tempted to release a biological agent within its own borders and accept 
casualties to its own people, knowing that this would frighten off a 
rich invader. There is some historical precedent for this. In World War 
I typhus epidemics were common on the Eastern front. The Serbians 
lost 150 000 men to typhus in the first 6 months of the war, including 
more than half of their 60 000 Austrian prisoners of war. 
Paradoxically, this actually aided the Serbs, because the Austrians 
were so frightened by the typhus epidemic that they kept their armies 
out of Serbia for fear of infection. Third World nations are also much 
more accustomed to death and illness due to extreme poverty. Perhaps 
this is one reason why the rich nations are so eager to ban germ warfare 
while keeping more expensive weapons of mass destruction in 
circulation. 
Biocrimes. Biocrime refers to the malevolent use of biological 
agents when the perpetrator’s motivation is personal, as opposed to a 
broader ideological, political, or religious objective. Although 
biocrimes constitute only a small fraction of criminal assaults and are 
usually unsuccessful, a well-executed attempt may be deadly; the 
resulting disease may pose clinical and forensic challenges. Biocrimes 
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have generally been more successful than bioterrorist attacks; 8 of 66 
biocrimes reviewed by Tucker produced 19 deaths and 31 injuries.  
Biocrimes are typically attempted by perpetrators with scientific 
or medical expertise or who have recruited suitably trained 
accomplices. One of the most striking examples of foodborne 
biocrime occurred in Japan between 1964 and 1966. Dr. Mitsuru 
Suzuki allegedly contaminated food items, medications, barium 
contrast, and a tongue depressor with Salmonella typhi and agents of 
dysentery on numerous occasions; these crimes resulted in over  
110 cases of infection and four deaths.  
A variation on the Suzuki crime occurred in 1996 when Diane 
Thompson, a hospital microbiologist, deliberately infected  
11 coworkers with Shigella dysenteriae. Eight of the 11 casualties and 
an uneaten muffin tested positive for S dysenteriae type 1, identical to 
the laboratory’s stock strain by pulsed-field electrophoresis. 
Murders by direct injection included the use of diphtheria toxin 
in Russia in 1910 and Y. pestis in India in 1933. The director of a 
Norwegian nursing home was convicted in 1983 of murdering  
11 patients by injecting them with a curare derivative. Biocriminals 
have also harnessed the most lethal emerging pathogen of the  
10th century; there have been at least four murder attempts by injecting 
victims with human immunodeficiency virus-infected blood. 
 
5.4 Long-term biological problems 
Many of the bioethics issues mentioned earlier are fashionable 
because of their technological novelty and seem likely to fade from 
public awareness relatively soon. What will mostly be left are 
underlying issues, such as access to health care and privacy, that apply 
both to new advances and to previous technology. However, there are 
several biological issues that are less romantic but may well be of more 
real importance. We will briefly mention these as a counterweight to 
topics such as human cloning. 
Two centuries of advancing medical technology have increased 
life expectancy from the mid-thirties to the mid-seventies in the 
industrial nations. Infant mortality has dropped from nearly 50 % to 
less than 1 %. The result is a population explosion that is far more 
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hazardous to the planetary environment that any high-tech tinkering 
with nature. Although antipollution measures and recycling may help 
slightly, the growth of the human population inevitably consumes 
more resources and encroaches on the natural world. 
Increased life expectancy also means that the average age of the 
human population is increasing. The ever greater proportion of old and 
retired people is putting a major strain on the health care systems of 
the advanced nations. Predictions of the coming collapse of American 
Medicare or the British National Health System are heard with 
increasing frequency. These trends are exacerbated by the high cost of 
much novel medical technology. In the United States some 20 % of 
expenditure is now in the general area of health care, and a vastly 
disproportionate amount is spent keeping old people alive for their last 
few months.  
Another factor is obesity. More and more the inhabitants of the 
advanced nations are getting fatter. This causes major health problems, 
many of which, like diabetes, need expensive long-term treatment. 
Population growth means increased crowding. Modern transport has 
led to increased mobility. The combination of these two factors has 
resulted in the rapid spread of infections around the world. From major 
pandemics such as AIDS and tuberculosis down to lesser epidemics 
such as cholera and West Nile virus, there are ominous signs that 
infectious disease is making a comeback. At the same time we have 
the spread of genetic resistance: to antibiotics among bacteria, to 
antivirals among viruses, and to insecticides among the insects that 
carry many infections or ravage crops.  
On the one hand, fending off novel or resistant infections is 
becoming ever more expensive in the rich nations. On the other hand, 
the spread of lethal infections is counteracting the population 
explosion to some extent in the poorer nations. This is especially 
evident in Africa, where actual population declines are predicted, 
largely as a result of AIDS. 
Listing problems tends to create a gloomy atmosphere. So let us 
end by saying that most problems today are the problems of success. 
Western science is responsible for today’s overpopulation precisely 
because it solved yesterday’s problems of famine and disease. We 
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believe that technology will solve many of the new generation 
problems. The foregoing list of issues should be viewed more as a to-
do list than a forecast of gloom and doom. 
 
Questions for Self-checking 
1. What are the main aspects of ethical problems dealing with 
infection deceases?      
2. Why infections are important? 
3. What main infection deceases do you know? 
4. What countries did participate in biological weapons creation 
in the 19th–20th centuries? 
5. Describe a role of Germany and the USA in germ warfare. 
6. What biological agents were produced by the US military? 
7. What does bioterrorism mean? 
8. What does biocrime refer to? 
9. List long-term biological problems. 
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